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resumo 
 
 
O código genético pode ser definido como uma série de reacções bioquímicas 
que estabelecem as regras pelas quais as sequências nucleotídicas do 
material genético são traduzidas em proteínas. Apresenta um elevado grau de 
conservação e estima-se que tenha tido a sua origem há mais de 3.5 mil 
milhões de anos. Ao longo dos últimos anos foram identificadas várias 
alterações ao código genético em procariotas e eucariotas e foram 
identificados codões ambíguos, sugerindo que o código genético é flexível. 
Contudo, os mecanismos de evolução das alterações ao código genético são 
mal conhecidos e a função da ambiguidade de codões é totalmente 
desconhecida.  
 
Nesta tese criámos codões ambíguos no organismo modelo Saccharomyces 
cerevisiae e estudámos os fenótipos resultantes de tal ambiguidade. Os 
resultados mostram que, tal como seria expectável, a ambiguidade do código 
genético afecta negativamente o crescimento, viabilidade celular e induz a 
produção de agregados proteicos em S. cerevisiae. Contudo, tal ambiguidade 
também resultou em variabilidade fenótipica, sendo alguns dos fenótipos 
vantajosos em determinados condições ambientais. Ou seja, os nossos dados 
mostram que a ambiguidade do código genético afecta negativamente a 
capacidade competitiva de S. cerevisiae em meio rico em nutrientes, mas 
aumenta a sua capacidade adaptativa em condições ambientais variáveis.  
  
Os efeitos negativos da ambiguidade do código genético, nomeadamente a 
agregação de proteínas, sugerem que tal ambiguidade poderá ser catastrófica 
em organismos multicelulares em que a taxa de renovação celular é baixa. 
Esta hipótese é suportada pela recente descoberta de uma mutação na alanil-
tRNA sintetase do ratinho que induz ambiguidade em codões de alanina e 
resulta numa forte perda de neurónios de Purkinge, neurodegeneração e morte 
prematura. Ou seja, a ambiguidade do código genético pode ter 
consequências negativas ou positivas dependendo do tipo de células e das 
condições ambientais. 
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abstract 
 
The genetic code is defined as a series of biochemical reactions that establish 
the cellular rules that translate DNA into protein information. It was established 
more than 3.5 billion years ago and it is one of the most conserved features of 
life. Over the years, several alterations to the standard genetic code and codon 
ambiguities have been discovered in both prokaryotes and eukaryotes, 
suggesting that the genetic code is flexible. However, the molecular 
mechanisms of evolution of the standard genetic code and the cellular role(s) of 
codon ambiguity are not understood. 
  
In this thesis we have engineered codon ambiguity in the eukaryotic model 
Sacharomyces cerevisiae to clarify its cellular consequences. As expected, 
such ambiguity had a strong negative impact on growth rate, viability and 
protein aggregation, indicating that it affects fitness negatively. However, it also 
created important selective advantages in certain environmental conditions, 
suggesting that it has the capacity to increase adaptation potential under 
environmental variable conditions.  
 
The overall negative impact of genetic code ambiguity on protein aggregation 
and cell viability, suggest that codon ambiguity may have catastrophic 
consequences in multicellular organisms. In particular in tissues with low cell 
turnover rate, namely in the brain. This hypothesis is supported by the recent 
discovery of a mutation in the mouse alanyl-tRNA synthetase which creates 
ambiguity at alanine codons and results in rapid loss of Purking neurons, 
neurodegeneration and premature death. Therefore, genetic code ambiguity 
can have both, negative or positive outcomes, depending on cell type and 
environmental conditions.    
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Chapter 1 
1. Introduction 
1.1. Genetic Code 
1.1.1. Genetic Code – Principal Features 
 
Established 3.5 billion years ago, the genetic code can be defined as a series of 
biochemical reactions that establishes the rules by which the nucleotides sequence of a genetic 
material (DNA or messenger RNA (mRNA)) is translated into proteins (Osawa, Jukes et al. 1992; 
Line 2002). Proteins are mainly composed by the same twenty amino acids specified by the 
genetic code in all known organisms. Amino acids are coded by a sequence of three adjacent 
bases, triplets, in the polynucleotide DNA or RNA sequence, namely, codons (Figure 1.1) (Woese 
1965; Crick 1968; Knight, Freeland et al. 2001).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The first two letters of the code (A, G, C or U) create sixteen possible combinations each 
of which are represented in a separated “codon box”. Each “codon box” displays four possible 
combinations, which will give a total of sixty-four codons. Of these, sixty-one are recognized by 
transfer RNAs (tRNAs) for the incorporation of twenty-two amino acids existent in proteins, and 
three codons stop mRNA translation (Agris 2004; Agris 2008). The genetic code is therefore 
Figure 1.1: The genetic code. The genetic code is composed by 64 codons 
and the amino acids specified by them. Codons are written 5´to 3´, as 
they appear in the mRNA. Highlight for the initiation codon (AUG) and the 
three termination codons (UAA, UAG and UGA) (Smith 2008). 
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degenerate because the great majority of amino acids have more than one codon. As a 
consequence, in all organisms codons out-number the tRNAs required to translate them.  
 
The disparity among the utilization of synonymous codons is named codon bias. Codon 
bias is characteristic of each one of the codons and is linked to tRNA isoacceptor abundance in the 
cell (Ikemura 1985). In turn, tRNA abundance is correlated to environmental responses (Nazario 
1972). The usage of rare codons in mRNA is associated with protein folding since there is a 
correlation between the codon usage in mRNA and topological features of the encoded proteins 
(Thanaraj and Argos 1996; Kimchi-Sarfaty, Oh et al. 2007).  
 
Even before the triplet nature of the genetic code was established it was suggested that 
proteins must be produced by “starting at a fixed point and working along the sequence of bases 
three at a time” (Crick, Barnett et al. 1961). These unique points are the starting and end points 
and the ribosome is somehow able to faithfully maintain the reading frame during decoding 
(Crick, Barnett et al. 1961).  A model that explains this is based on the fact that the anticodon of 
the tRNA consists of three nucleotides complementary to the codon and tRNA measure out the 
length of the codon using the anticodon as a yardstick (Holley 1965). More recent analysis reveal 
that when tRNA forms fewer than 3 base pairs with the mRNA, the interaction is insufficiently 
stable to preclude realignment of the tRNA with the peptidyl-tRNA site (P-site). A 4-nucleotide 
code was not adopted because of an insufficient need to encode more amino acids and/or a too 
stable, and irreversibility, tRNA-mRNA interaction (Farabaugh and Bjork 1999).  
1.1.2. Amino Acids and Evolution 
 
Amino acids are molecules that contain both amino (-NH2) and carboxyl (-COOH) 
functional groups. Each amino acid has a different side chain (R group) that defines them. With 
few exceptions, all organisms are restricted to the twenty common amino acid building blocks for 
the biosynthesis of proteins. Based on chemical and/or structural properties of R group, the 
amino acids can be classified as: aliphatic, cyclic, hydroxyl or sulfur containing side chains, 
aromatic, basic and acid (Table 1.1) (Issaq, Chan et al. 2009). Besides the canonical amino acids, 
two more non-canonical amino acids have been discovered, namely selenocysteine (Sec) and 
pyrrolysine (Pyl) that are present in some organisms.  
 
Early in the history of life only few of these twenty-two amino acids were encoded in the 
genetic code however, the composition of the initial group of amino acids remains a mystery. 
3 
 
Hypotheses to explain what are the ancient amino acids and the underlying genetic code are 
many and, one of the most famous is the theory of co-evolution. According to this, expansion of 
amino acids is achieved by biosynthetic transformation of precursor amino acids into product 
amino acids (Wong 1975). This hypothesis postulates that, the earliest proteins were constituted 
by prebiotic synthesized amino acids, namely, Gly, Ala, Ser, Asp, and Glu. Next three subsequent 
phases of amino acids incorporation into the code was followed (Wong 2005). Nevertheless, the 
theory of co-evolution is not unanimously accepted and the boundary between which were the 
ancient amino acids may be unrealistic because, with the exception of only three amino acids 
(Arg, Lys, and His), all others could be derived from prebiotic synthesis (Miller 1987). Another 
study showed that nine amino acids (Ala, Asn, Asp, Gly, His, Ile, Ser, Thr and Val) have a low 
frequency in proteins and could have been introduced early into the genetic code (once 
organismal diversification was in place) (Brooks, Fresco et al. 2002).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1.1: The twenty natural amino acids directed specified by the genetic code. The table contains the 
list of the twenty amino acids specified by the genetic code, the abbreviation of names and the principal 
chemical features of the amino acids;   
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1.2. Protein Biosynthesis  
1.2.1. Protein Biosynthesis - General mechanisms 
 
The cost of protein biosynthesis varies between the organisms, environmental conditions 
and resources availability, nevertheless this is arguably one of the most expensive universal 
cellular processes and a major component that sets metabolic rate (Waterlow 1984). Being 
divided in three major steps (amino acid synthesis, transcription and translation), protein 
synthesis expends at least 95% of metabolic energy in Escherichia coli (E. coli) and not much less 
in Saccharomyces cerevisiae (S. cerevisiae) (Jakubowski and Goldman 1992). Indeed, to synthesize 
the large ribosome RNA (rRNA) yeast cells spend approximately 60% of their energy (Li, Moir et al. 
2000).  
 
Translation is accomplished by ribosomes that act in concert with a large number of 
auxiliary factors in order to “translate” the information enclosed in mRNA. This is a multi-step 
process that can be, generally, divided into three phases: initiation, elongation and termination 
(Lackner and Bahler 2008). Some authors also consider a fourth phase named recycling (Kapp and 
Lorsch 2004). In each of these phases there are specific factors involved that are discussed bellow. 
The overall error rate in translation (10-3 and 10-4) is a net accumulation of errors from several 
steps, including transcription (≈10-4), aminoacyl-tRNA (aa-tRNA) synthesis (≈10-4), and ribosomal 
decoding (≈10-4) (Ling, Reynolds et al. 2009). The phases of translation in eukaryotes are discussed 
bellow. 
1.2.2. Initiation 
 
Taking place in the cytoplasm or across the membrane of endoplasmic reticulum (ER), 
translation initiation is a major target of mRNA regulation during protein synthesis (Macdonald 
2001; Dever 2002). Both in eukaryotes or prokaryotes initiation is the rate-limiting step and its 
efficiency depends on the sequence and structure of mRNA (Figure 1.2) (Skorski, Leroy et al. 2006; 
Nakagawa, Niimura et al. 2010). 
1.2.2.1. Initiation in prokaryotes 
 
In this section I we will provide the major characteristics of prokaryotic initiation. Taking E. 
coli as an example, the mRNA region important for translation initiation (translation initiation 
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region (TIR)) spans a few tens of nucleotides comprising the initiation codon, which is most 
frequently AUG (83%) and less common GUG and UUG, and the Shine-Dalgarno sequence (SD) 
(Shine and Dalgarno 1974; Shine and Dalgarno 1975; Ma, Campbell et al. 2002). This sequence 
(AGGAGG) is located approximately 4 to 15 nucleotides upstream of the initiation codon and pairs 
with a complementary sequence called anti-SD (CCUCC) located in the 3´ end of a 16 Svedberg (S) 
rRNA, the RNA from the 30S ribosomal subunit.  
 
However, the strength of the pairing between the SD and the anti-SD correlates only 
weakly with the efficiency of translation. Other determinants within the TIR have more decisive 
contributions to the efficiency of translation (Lee, Holland-Staley et al. 1996). Among these 
determinants the most well characterized are the binding site for ribosomal protein S1 (RPS1), 
which is a A/U region that stretches upstream the initiation codon and enhances translation due 
to the binding to RPS1 (Boni, Isaeva et al. 1991; Zhang and Deutscher 1992). Secondary structure 
in the mRNA can also inhibit translation by hampering the access of the 30S ribosomal subunit 
(Nakamoto 2006). Besides this, trans-acting factors, such proteins, RNAs, or metabolites may also 
bind to the mRNA enhancing or repressing its translation (McCarthy and Gualerzi 1990; Milon, 
Konevega et al. 2008). A wide spread bacterial example of RNAs that act as regulator of gene 
expression are the small non-coding RNAs (sRNAs) (Urban and Vogel 2007). These molecules (50 
and 200 nucleotides) act on trans-encoded target mRNAs influencing their translation and/or 
stability (Liu, Gui et al. 1997; Wassarman and Storz 2000). sRNAs normally have short and 
imperfect complementarity to their targets and this binding may result in either, the blockage of 
the ribosome entry or fusion of the inhibitory secondary structures. Regulation tends frequently 
to be linked to a nuclease-mediated cleavage of the mRNA (Masse, Escorcia et al. 2003).   
 
The mechanism of translation initiation in prokaryotes, according to the minimal kinetic 
model, can be divided in two phases (Gualerzi, Risuleo et al. 1977). In the first phase mRNA and 
initiator fMet-tRNA
fMet bind to the 30S subunit with the help of initiation factors (IFs). SD and anti-
SD pairing (SD interactions) and the subsequent formation of the 30S initiator complex (30S IC), 
composed by three IFs, mRNA and fMet-tRNA
fMet, ends this phase (Shine and Dalgarno 1974; Shine 
and Dalgarno 1975). In the second phase, the 50S subunit with the 30S IC associeted, GTP 
hydrolyses and the IFs dissociate. This phase is irreversible and results in the formation of 70S IC 
that is ready for the elongation phase (Gualerzi, Brandi et al. 2001).  
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1.2.2.2. Initiation in eukaryotes 
 
Translation initiation in eukaryotes is accomplished in four steps: (i) formation of a 43S 
pre-initiation complex; (ii) recruitment of the 43S complex to the 5´ end of mRNA; (iii) scanning of 
the 5´ UTR (untranslated region) and start codon identification; (iv) formation of the complete 80S 
ribosome (Preiss and Hentze 2003). 
 
i) Formation of a 43S pre-initiation complex 
 
The first step of initiation is needed to promote the dissociation of the ribosomes into 
their subunits (Preiss and Hentze 2003). Conversely to what happens in bacteria, where the 
dissociation of free 70S ribosomes is known to be catalyzed in the presence GTP, by elongation 
factor G (EF-G), initiation factor 3 (IF3) and ribosome recycling factor (RRF) (Hirokawa, 
Demeshkina et al. 2006), in eukaryotes the process of dissociation is still unclear (Demeshkina, 
Hirokawa et al. 2007). Because physiological conditions favor the association of ribosomal 
subunits (40S and 60S), the intervention of initiation factors (IF) is required. Several have 
ribosome anti-association/dissociation activity, namely, eIF1, eIF1A and eIF3 (Preiss and Hentze 
2003). At low free Mg2+ concentration (1 mM) eIF3, in cooperation with its poorly associated eIF3j 
subunit eIF1 and eIF1A, is responsible for the dissociation of the 80S ribosome into free 60S 
subunits, mRNA and tRNA-bound 40S subunits (Jackson, Hellen et al. 2010). More specifically, 
following this initially dissociation eIF1 promotes release of the tRNA and eIF3j mediates mRNA 
dissociation. The re-association of the 40S and 60S subunits is prevented by eIF3, and probably 
eIF1 and eIF1A, which remain associated with recycled 40S subunits (Jackson, Hellen et al. 2010).  
 
The following step in initiation is the binding of eIF2 to the initiator transfer RNA (tRNAi), 
Met-tRNAi, in a GTP-dependent manner, forming a ternary complex composed by eIF2, GTP and 
methionine initiator tRNA (eIF2– GTP– Met-tRNAi) (Merrick 1992; Kapp and Lorsch 2004). The 
eIF2 factor is a heterotrimer of α, β and γ subunits with a molecular mass ranging between 35 to 
52 kDa (Merrick 1992). The γ-subunit binds both GTP and Met-tRNAi. Subunit β is responsible for 
GTPase activity and modulates initiator tRNA binding of eIF2γ. For the formation of this complex 
the intervention of guanine nucleotide exchange factor (GEF) eIF2B is also needed. The eIF2B 
contains five polypeptides (α, β, γ, δ, and ε) with molecular mass not larger than 82 kDa. This 
factor favors the recycling of eIF2-GDP, a product of initiation, to eIF2-GTP in the end of each 
initiation cycle to allow a new round of initiation (Preiss and Hentze 2003). This happens because 
eIF2 was a 100-fold higher affinity for GDP than GTP (Kapp and Lorsch 2004) and the off-rate 
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constant for GDP release is slow. A similar situation happens in the bacterial elongation cycle with 
EF-Tu having also a 100-fold preference for GDP. Subunit α of eIF2 presents a central role as a 
regulator of translation initiation, being involved in the interactions between eIF2 and eIF2B. 
Indeed, phosphorylation of this subunit carried out by specific eIF2-kinases constitutes a major 
means of regulating translation in response to different forms of cellular stress (Preiss and Hentze 
2003). After assembly the ternary complex, binds to the 40S with the help of at least, eIF1, eIF1A 
and the multisubunit factor eIF3. The resulting complex is called 43S (Kapp and Lorsch 2004). In 
yeast, an additional step occurs, independently of the ribosome. A multifactor complex (MFC) of 
eIF1, eIF2, eIF3, eIF5 and Met-tRNAi assembles. MFC may be an important functional unit during 
several stages of translation initiation (Asano, Clayton et al. 2000). eIF5 is a single polypeptide 
chain of 46 kDa in yeasts that presents a ribosome-dependent GTPase activity, appropriate for its 
proposed role in subunit joining (Merrick 1992). This translation factor is catalytically the most 
active. 
 
ii) Recruitment of the 43S complex to the 5´ end of mRNA 
 
The recruitment of the 43S pre-initiation complex to the 5´ end of mRNA begins with the 
assembly of the eIF4F complex on the 5´ cap of the mRNA and the, subsequent, unwinding of 
structures found in the 5´ UTR (Kapp and Lorsch 2004). eIF4F is an heterotrimeric complex 
composed by eIF4G, the cap-binding protein eIF4E and the ATP-dependent RNA helicase eIF4A 
(Preiss and Hentze 2003). eIF4G is a multivalent adaptor that functions like the core of eIF4F and 
appears to constitute the primary ribosome recruitment module. eIF4E is a factor that enhances 
the binding of the eIF4F complex to the 5´ end of the mRNA. The last factor of the eIF4F complex, 
eIF4A, is a DEAD box helicase that can unwind RNA secondary structures in an ATP-dependent 
manner (Pause, Methot et al. 1994). This helicase function of eIF4A is assisted by the RNA-binding 
protein eIF4B (homodimer that can bind RNA by virtue of an RNA recognition motif (RRM)) 
(Pause, Methot et al. 1994). Recently, another factor involved is this process was identified. That 
factor, eIF4H, has homology to the RRM domain of eIF4B and has been shown to stimulate 
ATPase and helicase activity of eIF4A (Preiss and Hentze 2003). eIF3 and poly(A)-binding protein 
(PABP) bound to the 3´ poly(A) tail are also required for binding of the 43S complex to the mRNA 
(Lamphear, Kirchweger et al. 1995).  
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iii) Scanning of the 5´ UTR and start codon identification 
 
The scanning process requires ATP hydrolyses, although the ATPase involved has not yet 
been identified (Kapp and Lorsch 2004). After the assembly of the 43S complex near the 5´ end of 
the mRNA the complex needs to find the appropriate starting codon. Marilyn Kozak proposed a 
linear movement of the 43S along the mRNA 5´ UTR in search for the triplet, this mechanism is 
known as the scanning mechanism (Kozak 2002). This process is consistent with a large body of 
genetic and biochemical data, and explains the “first-AUG rule” - initiation should occur on the 
start codon closest to the mRNA 5´ end. Kozak proposed that factors eIF1 and eIF1A may play an 
important function during scanning, and recent biochemical data show that eIF1 plays an 
important role during selection in the selection of the start codon (Pestova and Kolupaeva 2002). 
According to Pestova and Kolupaeva (2002) 43S complex exists in two conformations, namely a 
closed conformation which is scanning-incompetent in absence of eIF1, and an open 
conformation which is scanning-competent when eIF1 is present. Only 43S open complex can 
establish stable interactions with the cognate AUG triplets located in a proper nucleotide context. 
The favorable nucleotide context is termed the “Kozak sequence” and is fundamental for 
initiation (Kozak 2002). When the 43S complex encounters correct codon-anticodon base pairing 
between the initiation codon and the initiator tRNA in the ternary complex the conformation of 
the 40S-subunit-bound eIF2 changes triggering GTP hydrolysis by eIF2, which is facilitated by the 
GTPase-activating protein (GAP) eIF5 (Sokabe, Yao et al. 2006). After GTP hydrolysis, the complex 
eIF2-GDP releases the Met-tRNAi into the P-site (peptidyl-tRNA site) of the 40S subunit and then 
dissociates. At this point eIF1, eIF1A, eIF3 and eIF5 also dissociate. Until recently, GTP hydrolysis 
by eIF2 was thought to be sufficient for 60S joining. However, in vitro experiments revealed that a 
second GTPase, eIF5B, is required (Lee, Pestova et al. 2002). For that, before or after the 
hydrolysis of GTP, eIF5B-GTP binds to the complex and stimulates 60S joining.   
 
iv) Formation of the complete 80S ribosome 
 
For the joining of the 60S subunit to the 40S scanning subunit, initiation factors have to 
dissociate from the latter (Kapp and Lorsch 2004). This last event, combination of 40S and 60S 
subunit, triggers GTP hydrolysis by eIF5B and then eIF5B-GDP dissociates from the complex, 
because of its low affinity for the ribosome (Pestova and Kolupaeva 2002). Although other steps 
may be required, this is thought to be the end of translation initiation. Briefly, the formation of an 
elongation competent 80S ribosome requires two distinct GTP hydrolysis steps that serve as 
checkpoints for proper identification of AUG codon and 80S (Preiss and Hentze 2003). 
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1.2.3. Elongation 
 
The elongation machinery is highly conserved across the three kingdoms of life. For 
example, there is strong similarity between the different elongation factors (Merrick 1992), the 
human eEF1α and E. coli EF-Tu are 33% identical overall. Among EF2 homologs, EF2 from 
Halobacterium halobium (H. halobium) is 36% identical to eEF2 from S. cerevisiae and 30% to E. 
coli EF-G. Exceptions from the similarities are a variety of posttranslational modifications of both 
factors that only occur in eukaryotes (Kapp and Lorsch 2004). Consequently, mechanisms 
underlying elongation are similar in eukaryotes, bacteria and archaea. To explain the elongation 
mechanism many models have been proposed, but I will focus on the better-established bacterial 
model proposed by Moazed and Noller (Figure 1.3) (Moazed and Noller 1986). 
 
According to that model, peptide chain elongation in eukaryotes begins with the initiator 
peptidyl tRNA firmly entrenched in the P-site of the 80S ribosome. The repetitive cycle for the 
codon-directed addition of aa-tRNAs begins with an aa-tRNA carried to the aminoacyl-tRNA site 
(A-site) of ribosome as part of a ternary complex composed by GTP and eEF1α (EF-Tu in bacteria). 
With the GTP and aa-tRNA, eEF1α catalyzes the binding of aa-tRNA to the ribosome, in a codon-
dependent manner, through hydrolysis of GTP (Urban and Vogel 2007). To ensure that only the 
cognate tRNA is selected for the next cycle of elongation several processes that I will discuss later 
take place. In addition to the already mentioned codon-anticodon base pairing between the 
mRNA and the tRNA and GTP hydrolysis by eEF1α, conformational changes in the decoding center 
of the small ribosomal subunit must occur (Rodnina and Wintermeyer 2001). The codon-
anticodon pairing induces three bases in the small ribosomal subunit rRNA to swing out 
interacting with the mRNA-tRNA duplex formed. Consequently, eEF1α (EF-Tu in bacteria) GTPase 
activity is activated and the resulting eEF1α – GDP releases the aminoacyl-tRNA into the A-site in a 
form that can continue with peptide bond formation (complex EF1α – GDP is released).  
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Figure 1.2: Translation initiation. Schematic overview of translation initiation in the three domains of life: 
bacteria, archea and eukaryote. Universally conserved factors IF1/eIF1A (yellow), IF2/eIF5B (blue) and 
archea and eukaryote eIF2 (red) are highlighted. The cap/poly-A-binding complex (only in eukaryotes) is in 
light blue. SD – Shine-Dalgarno sequence (Marintchev and Wagner 2004). 
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The presence of aa-tRNA in the A-site is very short lived because the ribosomal peptidyl 
transferase center quickly catalyzes the formation of a peptide bond between the incoming amino 
acid and the peptidyl-tRNA (Merrick 1992). Shortly, in this reaction, there is a nucleophilic attack 
by the α-amino group of the aminoacyl-tRNA in the A-site on the carbonyl of the ester linkage of 
the aa-tRNA (or peptidyl-tRNA) in the P-site. Resulting from that is a deacylated tRNA in a hybrid 
state with its acceptor end in the exit site (E-site) of the large ribosome subunit and its anticodon 
end in the P-site of the small subunit.  In a similar hybrid situation is the peptidyl-tRNA with its 
acceptor end in the P-site of the large subunit and its anticodon end in the A-site of the small 
subunit. At this point a translocation must occur in such a way that the deacylated tRNA is 
completely in the E-site, the peptidyl tRNA fully in the P-site, and the mRNA moved by three 
nucleotides (one codon) so that a new codon is located in the A-site. This task is accomplished by 
eEF2 (EF-G in bacteria) in a GTP-dependent manner (Kapp and Lorsch 2004). As a consequence of 
this action, and in consonance with biophysical data, the growing polypeptide chain elongates but 
does not move (Odom, Picking et al. 1990). After the hydrolysis of GTP, and the release of eEF1α – 
GDP, this complex is recycled to its GTP-bound form so that it may participate in successive 
rounds of polypeptide elongation. This exchange is catalyzed by a multifactor complex called 
eEF1-βγ. For the eEF2 (and EF-G) there is no known guanine-nucleotide (Merrick 1992).  
 
Figure 1.3: Elongation cycle in eukaryotes. This schematic representation follows the assumptions 
of the “half-site” model of Moazed and Noller and is based on the similarities between the structure 
and function of the eukaryotic and prokaryotic elongation factors. E – exit site; P – peptidyl-tRNA 
site; A – aminoacyl-tRNA site (Merrick 1992). 
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Energetically, the elongation is the step where most of the energy required for protein 
synthesis is consumed. Two high-energy phosphates (eEF1α and eEF2) are used per cycle and 
another two high-energy phosphates are used to generate each aa-tRNA (ATP + aa + tRNA -> AMP 
+ PPi + aa-tRNA). Thus the formation of each peptide-bound costs four high-energy phosphates 
(Kapp and Lorsch 2004). 
1.2.3.1. Elongation Factor 3 (eEF3) – An exception to elongation conservation 
 
The major exception to the role of conservation in the translation elongation mechanism 
is the existence of elongation factor 3 (eEF3) exclusively in fungi (Figure 1.4) (Blakely, Hekman et 
al. 2001). This factor was discovered by Skogerson and co-workers (1976) and is required for in 
vitro protein synthesis by yeast ribosomes in addition to eEF1 and eEF2 (interchangeable with the 
eukaryotes homologous) (Skogerson and Wakatama 1976). Besides that function, some additional 
roles for eEF3 in fungi are currently known and, one of the most recent, is the association of the 
eEF3 with a calcium channel in the plasma membrane (Liu and Gelli 2008). Purified from several 
fungal species eEF3 consists of a single polypeptide chain with a molecular weight of about 125 
kDa (Qin, Xie et al. 1990). The YEF-3 gene that codes for eEF3 is essential for viability in yeast and 
is located on chromosome XII. 
 
 
 
 
 
 
 
 
 
 
 
 
The eEF3 protein possesses ribosome-dependent ATPase and GTPase activities and 
contains a duplicated nucleotide binding motif homologous to those found in the typically 
membrane-associated ATP binding cassette (ABC) proteins (Belfield and Tuite 1993). It performs a 
vital role in protein translation, where it enables efficient binding of the eEF1A – GTP – aa-tRNA 
Figure 1.4: Elongation factor 3 (eEF3). Cryo-electron microscopy structure of S. cerevisiae ATP-
bound form of eEF3 in complex with the post-translocational-state 80S ribosome. Highlighted 
one the constitutive amino-terminal HEAT repeat domain and two ABC-type ATPase domains 
(Andersen, Becker et al. 2006).  
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ternary complex to the ribosomal A-site and facilitate the release of deacylated tRNA to the 
ribosomal E-site. In doing that eEF3 appears to maintain a balance between the protein 
translation rate and amino acid fidelity (Liu and Gelli 2008). 
 
Mammalian ribosomes possess an intrinsic eEF3 like activity however no mammalian 
candidate has yet been identified as the homologue of fungal eEF3. In bacteria, E. coli has a 
soluble ribosome-dependent ATPase, RbbA, which require the hydrolysis of ATP for its functions 
and has some sequence similarity to eEF3 (Kapp and Lorsch 2004). Due to its unique occurrence in 
fungi and the lack of a homologue in the mammalian cells eEF3 is a promising drug target for the 
development of anti-fungals. Identification and characterization of this factor among diverse fungi 
of medical importance may be essential for the design of pharmacological inhibitors with broad 
specifity. Thus far, the major limitation relates to the fact that eEF3 has only been cloned and 
characterized from yeasts of the order Ascomycota as well as the fungus-like organism 
Pneumocystis carinii (Blakely, Hekman et al. 2001). Basidiomycete yeasts are distinct either in 
morphology and 18S ribosomal DNA sequence criteria (Qin, Xie et al. 1990). 
1.2.4. Termination  
 
In the standard genetic code, sixty-one sense codons are decoded by cognate transfer 
RNAs aminoacylated by twenty natural amino acids (Seit-Nebi, Frolova et al. 2002). With these 
twenty amino acids a tremendous number of different polypeptide chains can be formed. The 
marker for translation termination comes with the appearance of one of the three stop codons 
(UAA, UGA and UAG). These three codons are also designated nonsense codons and were 
identified in the mid 60’s - UAA and UAG (Weigert and Garen 1965) and UGA (Brenner, Barnett et 
al. 1967).  These triplets in mRNA function in vitro as signals for release of polypeptide chains 
from ribosomes (Inge-Vechtomov, Zhouravleva et al. 2003). The existence of these three stop 
codons is true in organisms with a universal genetic code, whereas, in ciliates with variant code, 
only one or two codon(s) remain(s) (Seit-Nebi, Frolova et al. 2002).  
 
The nonsense codons were recognized by specific termination recognition proteins called 
class 1 polypeptide release factors (RF) (Merrick 1992). The class-1 RF (which comprises 
prokaryotic RF1 and RF2 and eukaryotic eRF1) recognize stop codons and transfer the signal from 
the mRNA stop codon occupying the A-site of the ribosome to the peptidyl transferase center, 
inducing the hydrolysis of peptidyl-tRNA catalyzed by the peptidyl transferase center of the 
ribosome (Inge-Vechtomov, Zhouravleva et al. 2003). Despite having the same function, 
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eukaryotic and prokaryotic class 1 release factors do not present any obvious sequence 
homology. eRF1 is composed by three domains: N (or 1) that participate in stop codon recognition 
(Seit-Nebi, Frolova et al. 2002), M (or 2) responsible for the peptidyl transferase hydrolytic activity 
(Frolova, Tsivkovskii et al. 1999) and C (or 3) that are not involved in stop codon recognition but 
binds to the second termination factor eRF3 (Inge-Vechtomov, Zhouravleva et al. 2003). In 2002, 
Seit-Nebi and co-works postulated a novel decoding mechanism for the eukaryotic class 1 RFs and 
the principal findings are: (i) the recognition of the stop codon involves two distinct mini domains 
(Y-C-F and NIKS) of the N domain of eRF1; (ii) the recognition of some stop codons in organisms 
with a non-universal genetic code is limited by the existence of negative determinates 
(constraints) in eRF1 (Seit-Nebi, Frolova et al. 2002). 
 
The class-2 RF (prokaryotic RF3 and eukaryotic eRF3) are GTPases which one not required 
in vitro for the peptide release reaction itself but stimulate the activity of class 1 regardless of 
which stop codon class 1 factor is engaged. RF3 and eRF3 functions in similar ways, however they 
present important structural differences between them (Kisselev, Ehrenberg et al. 2003). 
 
So, in bacterial systems there are three RF, two of which have different codon 
specificities: RF1 (UAA, UAG) and RF2 (UAA, UGA). The third release factor, RF3, has no codon 
specificity and its function is to stimulate RF1 and RF2 activity (Inge-Vechtomov, Zhouravleva et al. 
2003). Conversely to bacterial systems, eukaryotic, archea and mitochondria have only two RF 
(Kisselev, Ehrenberg et al. 2003): eRF1 (gene SUP45 in S. cerevisiae) which governs the 
termination of translation recognizing the three nonsense codons and eRF3 (gene SUP35) which 
stimulates the activity of eRF1 (Inge-Vechtomov, Zhouravleva et al. 2003) (Figure 1.5). The action 
of eRF1 and eRF3 can extend besides translation termination. In S. cerevisiae a numerous number 
of pleiotropic effects of sup45 and sup35 mutations are identical. These findings are in 
consonance with the notion that these two genes operate together either in translational 
termination or in several other cellular processes. The transcripts of these genes interact with 
other proteins and some of the examples are components of the translation termination complex 
like PABP and a number of Upf proteins (Inge-Vechtomov, Zhouravleva et al. 2003).   
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1.2.4.1. [PSI+] cells 
 
Like many other proteins in yeast, eRF3 (Sup35) has prion-like properties. The aggregated 
form of Sup35 results in a cytoplasmically inherited suppressor element called as [PSI+]. One of 
the well-known phenotypic features of [PSI+] is stop codon suppression. The Hsp104 protein plays 
an important role in prion formation as it was shown that it is required for formation and 
maintenance of [PSI+] aggregates of eRF3. Its overproduction or inactivation cures cells of [PSI+] 
(Cosson, Couturier et al. 2002). 
1.2.4.2. Nonsense-mediated mRNA decay (NMD)  
 
During the protein synthesis aberrant proteins can be produced. Some of these aberrant 
transcripts contain a premature termination codon (PTC) that codes for potentially deleterious 
protein fragments (Inge-Vechtomov, Zhouravleva et al. 2003). In these cases a surveillance 
complex forms and triggers rapid mRNA decay via the nonsense-mediated mRNA decay (NMD) 
pathway.  
 
In yeasts, during premature translation termination the mRNA surveillance complex 
composing Upf proteins and release factors is assembled. This complex searches 3´ of the 
termination codon for specific signals that target the mRNA for rapid degradation. When such 
signal is found, the transcript is rapidly decapped by Dcp1p, followed by 5´ to 3´ decay by 
exonuclease Xrn1p (Wang, Czaplinski et al. 2001).  
 
Figure 1.5: Translational termination complex. Scheme of the translational 
termination complex formed when the ribosome elongation machinery (dotes) 
finds a termination codon. Interaction between PABP and eIF (green) are 
fundamental to the ribosome recycling (Inge-Vechtomov, Zhouravleva et al. 
2003). 
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The identification of UPF homologs in different organisms suggests that NMD is an 
evolutionarily conserved pathway of RNA degradation in eukaryotes (Inge-Vechtomov, 
Zhouravleva et al. 2003). In yeasts, Upf1 protein (and SMG1 factor) interacts with both translation 
factors eRF1 and eRF3 (forming a complex named SURF), and likely influences translation 
termination efficiency (Funakoshi, Doi et al. 2007). On the other hand, Upf2p and Upf3p interact 
only with eRF3 and compete with eRF1 for binding eRF3 (Wang, Czaplinski et al. 2001).  When 
eRF1 dissociates, it allows either Upf2 or Upf3 to bind to the eRF3-Upf1 complex.  Since eRF3 
blocks the ATPase-helicase activity of Upf1p, the activation of the surveillance complex requires 
dissociating of eRF3 from the Upf complex. Degradation by the NMD pathway is independent of 
prior deadenylation of the mRNA and Pab1p is unable to prevent the decay of mRNA subjected to 
NMD. Therefore, it is not likely that Pabp1 out-competes Upf proteins for binding to eRF3 
(Cosson, Couturier et al. 2002).  
1.2.5. Recycling 
 
The fourth and final stage of translation is the recycling of the ribosomal subunits. In 
bacterial systems after termination of translation, one more protein factor, RRF, is involved. The 
function of RRF is to recognize the ribosome that was left on the mRNA with a deacylated tRNA. 
Probably this ribosome is in a P/E hybrid state in which the acceptor end of the tRNA is in the E-
site of the 50S subunit and the anticodon end is in the P-site of the 30S subunit (Kapp and Lorsch 
2004). With the help of the tRNA translocation factor EF-G and eIF3, RRF recycles the ribosome 
for a new round of initiation (Kisselev and Frolova 1999; Kisselev, Ehrenberg et al. 2003). The 
recycling of ribosomes is believed to occur by splitting the ribosome into its subunits promoting 
the dissociation and release of the tRNA and mRNA. In eukaryotic cells, no specific recycling factor 
has been identified so far and there is no evidence of a RRF ortholog (Kapp and Lorsch 2004). In 
the group of factors proposed to be involved in ribosome recycling, eIF3 is the most intriguing. A 
variety of experiments indicate that eIF3 binds to 40S subunits inducing a conformational change 
that could, potentially, increase the rate of subunit dissociation as well as lowering the rate of 
association. In order to explain recycling in eukaryotes the closed-loop model postulates that, 
contrary to the bacterial system, termination and recycling may not release the 40S subunit back 
into the cytoplasm (Kean 2003). Instead, 40S subunits may be shuttled across or over the poly(A) 
tail back to the 5´ end of the mRNA via the 5´ and 3´ end associated factors. The closed loop 
serves to facilitate re-initiation of translation rather than the first initiation event. The finding that 
eRF3 and PABP interact with each other, connecting the termination apparatus to the poly(A) tail 
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is in accordance with this proposal. Another argument in favor of this model is the finding that the 
disruption of the PABP-eRF3 interaction inhibits translation and that addition of eRF3 to in vitro 
translation assays stimulates the initiation process (Uchida, Hoshino et al. 2002). This hypothesis 
has not been verified in vivo but is in agreement with the size and properties of all proteins. In this 
study performed by Uchida and co-workers (2002) another argument in favor of this model was 
revealed. This study showed that GSPT (mammalian eRF3) associates with eIF4G through PABP 
and that the GSPT-PABP interaction is involved in many rounds of translation. Through the action 
of a complex composed of poly(A)-PABP-eIF4F-cap the mRNA is circularized and the effect is an 
enhancement in translation. In this hypothetical model a translation-terminating ribosome may 
be recruited to the next translation initiation. In situations where stop codons are distant from 
the poly(A) tail, a bridging protein is needed to physically couple them and allow the recycling of 
ribosomes. The fact that GSPT interacts with eRF1 and PABP at the same time suggests that GSPT 
may perform this function. In this model, the 3´ UTR that is located between a stop codon and the 
poly(A) tail could be looped out, and the terminating ribosome could be passed to the 5´ cap 
through a novel protein bridge consisting of eRF1, GSPT, PABP and eIF4F. 
 
In Humans there are two distinct eRF3 genes, termed GSPT1 and GSPT2, and structurally 
both subtypes consist of an N-terminal region and a C-terminal eEF1 α-like GTP-binding domain. 
C-domain interacts with eRF1 and is sufficient for the termination reaction. The N-domain 
associates with PABP and inhibits its multimerization (Uchida, Hoshino et al. 2002). 
1.2.6. Poly(A)-binding protein 
 
 
The poly(A)-binding protein (Pabp1 for yeasts) presents two major functions in the cell: 
mRNA stabilization regulates the poly(A) tail length during the polyadenylation reaction and 
prevents deadenylation and translation enhancement efficient translation requires the synergistic 
interplay between 5´ cap and 3´ end poly(A) tail of mRNA (Cosson, Couturier et al. 2002; Uchida, 
Hoshino et al. 2002). The latter appears to be independent of its binding to eIF4G and all these 
activities involve the N-terminal part of Pab1p. Another function assigned to Pab1p is an anti-
suppressor effect in vivo. This effect requires the site of the binding of Pab1p to eRF3, suggesting 
that Pab1p has an anti-suppressor effect on translation termination through its interaction with 
eRF3. The interactions between eRF3 and PABP are evolutionarily conserved and occur in the N-
terminal domain of eRF3 (Cosson, Couturier et al. 2002). In Human cells, when the eRF3-PABP 
interaction is inhibited the ribosome recycling is prevented. These data also supports the 
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existence of a protein complex including eRF1-eRF3-PABP-eIF4F, which mediate the coupling of 
termination and the initiation of protein synthesis. This complex may also be responsible for 
deciding what percentage of the 40S subunits may remain attached to the mRNA (Uchida, 
Hoshino et al. 2002).       
1.2.7. Deadenylation 
 
Control of mRNA decay is a fundamental step in the control of the amount of protein 
produced from the mRNA by translation. The decay is intimately linked and regulated by 
translation (Funakoshi, Doi et al. 2007). Defined as the exonucleolytic degradation of the 3´ 
poly(A) tail of eukaryotic mRNAs, deadenylation is an important step in both mRNA degradation 
and translational silencing (Dehlin, Wormington et al. 2000).  
 
The major pathways of mRNA decay characterized so far in yeast and mammalian cells 
are: mRNA decay directed by AU-rich elements (AREs) in the 3´ UTR, decay mediated by 
destabilizing elements in protein-coding regions, NMD and decay directed by microRNAs (Zheng, 
Ezzeddine et al. 2008). The first major step in all these decay pathways is deadenylation. This 
process is the rate-limiting and the most efficient step in controlling mRNA decay (Funakoshi, Doi 
et al. 2007). Deadenylation can be divided in two phases. In the first phase poly(A) tails are 
shortened to approximately 110 nucleotides by the action of Pan2 in association with Pan3 (in 
yeast Pan3 does not exhibit poly(A) nuclease activity but is necessary for a proper function of 
Pan2) (Zheng, Ezzeddine et al. 2008). In the second phase of deadenylation, a complex composed 
of Ccr4 and Caf1 catalyze further shortening of poly(A) tail to oligo(A). Decapping by the Dcp1-
Dcp2 complex may occur during and/or after the second phase of deadenylation (Zheng, 
Ezzeddine et al. 2008). In this processes two major mRNA deadenylase complexes (Caf1-Ccr4 and 
Pan2-Pan3) play a central role and both have been identified in yeasts and mammals (Funakoshi, 
Doi et al. 2007). The cytoplasmatic deadenylase complex Ccr4-Caf1 has significant homology with 
known 3´ to 5´ exonucleases and both proteins have catalytic activity. The other major complex, 
PAN, is a heterodimeric protein consisting of catalytic Pan2 and regulatory Pan3 subunits. Since 
the rate-limiting step for mRNA decay is the deadenylation, the enzymatic activity of these two 
deadenylases constitutes a major target for the control of mRNA decay. Deadenylation, and decay 
of a normal mRNA, is mediated by the action of eRF3 in a manner coupled to translation 
termination. Funakoshi and co-workers (2007) postulated that eRF3 mediates deadenylation 
through Ccr4-Caf1 and Pan2-Pan3 deadenylase (Funakoshi, Doi et al. 2007). The termination 
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complex eRF1-eRF3 and deadenylase complexes hPan2-hPan3 and hCaf1-hCcr4 interact with 
PABPC1. The binding of hPan2-hPan3 and hCaf1-hCcr4 with PABPC1 triggers the deadenylase 
activity (Uchida, Hoshino et al. 2004).       
 
One consequence of deadenylation is the formation of nontranslatable mRNA protein 
complexes (messenger ribonucleoproteins - mRNPs). These nonstranslatable mRNPs may 
accumulate in P-bodies (composed by factors involved in translation repression, decapping and 5´ 
to 3´ degradation). In a 2008 study, Zheng and co-workers demonstrated that deadenylation is 
required for mammalian P-body formation and mRNA decay (Zheng, Ezzeddine et al. 2008). Pan2, 
Pan3 and Caf1 deadenylases were identified as new P-body components and show that Pan3 
helps recruit Pan2, Ccr4, and Caf1 to P-bodies. When deadenylation is blocked P-bodies are not 
detected. The findings of this paper support the idea of a dynamic interplay among 
deadenylation, mRNP remodeling, and P-body formation in selective decay of mammalian mRNA. 
According to the model proposed Pan2-Pan3 and Ccr4-Caf1 complexes forms a super complex on 
mRNAs in the cytoplasm. In the first phase, 3´ poly(A) tail-PABP complex stimulates poly(A) 
shortening by the Pan2-Pan3 in the super complex. In this phase, the activity of Ccr4-Caf1 is 
inhibited and mRNP remodeling occur (dissociation of PABPs and some translation initiation 
factors and association of translation repressors). The remodeled mRNP (now in a nontranslatable 
state) may associate with existing P-bodies or nucleate formation of new P-bodies, in which the 
second phase of deadenylation by Ccr4-Caf1 and/or decapping would proceed. In alternative, a 
remodeled mRNP undergo the second phase of deadenylation outside P-bodies. This could induce 
another mRNP remodeling that determines whether the oligo(A)-mRNP would be degraded inside 
or outside of P-bodies. After those two general pathways occur, the mRNA is degraded in the 5´ to 
3´ direction by Xrn1p in decapping complexes and in the 3´ to 5´ direction by exosomes. An 
important conclusion from these findings is that although P-bodies may be assembled via 
different mechanisms, deadenylation is always a necessary step that enables mRNPs to enter 
existing P-bodies or to initiate the formation of new ones (Figure 1.6).  
1.3. tRNAs and aminoacyl-tRNAs synthesis 
1.3.1. tRNA 
 
Cellular life is based on the translation of the four-letter code of RNA into the twenty two-
letter alphabet of proteins. A crucial feature of this process is the fidelity with which mRNA is 
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translated during protein synthesis. During this process the cell utilizes aa-tRNAs as building 
blocks, which are produced by aminoacyl-tRNA synthetases (aaRSs) and delivered to the ribosome 
by EF-Tu (in bacteria) or eEF1α (archaea and eukaryotes). To ensure the fidelity necessary in 
protein synthesis two main determinants exist: the availability of aa-tRNAs composed of cognate 
amino acid:tRNA pairs and the accurate selection of aa-tRNAs on the ribosome (Ling, Reynolds et 
al. 2009).  
 
 
 
 
     
 
 
 
 
   
 
 
 
 
 
Modern day proteins are synthesized in ribosomes, a complex molecular machine 
composed of proteins and RNA. The relatively small tRNA adaptors are central to this process 
(Sun, Li et al. 2008). tRNA is a molecule composed of RNA that functions as an adaptor in the cell 
to bridge the genetic code in mRNA with the twenty two-letter code of amino acids in proteins. 
Typically with a length of 73 to 93 nucleotides the role of tRNA as an adaptor is best understood 
by considering its three-dimensional structure. RNA forms double-helical structures with Watson-
Crick base pairing but it contains many noncanonical base pairs, and even triplets, that allow it to 
fold into its unique three-dimensional structure. Conformational studies reveal a strong tendency 
for its strands to follow an A-helical pathway, even in non-base-paired regions (Noller 2005). A 
characteristic motif is the U-turn, of the anticodon loop of tRNA, which causes an abrupt reversal 
in direction of the RNA chain. tRNA structure also possess the coaxial stacking of RNA helices: the 
acceptor stem of 7 base-pairs (bp) stacks on the 5-bp T stem to form one continuous A-form 
Figure 1.6: Model linking deadenylation, P-bodies, and mRNA decay. Schematic figure of the postulated 
relations between deadenylation of mRNA, the P-bodies formation and the mRNA 5´ to 3´ and 3´ to 5´ decay 
(Zheng, Ezzeddine et al. 2008). 
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helical harm of 12-bp. The two other helices, the D stem and anticodon stem, also stack, although 
imperfectly, to form a second helical arm. The two coaxially stack arms are responsible for the 
distinctive L form of tRNA (Figure 1.7).  
 
The cells devote a great deal of resources to the modification of RNA. Indeed, 
considerably more genetic information is allocated to tRNA modification than to tRNA genes 
(Gustilo, Vendeix et al. 2008). There is a great number, almost a hundred, of tRNA post-
transcriptional modifications identified so far. Some of the modifications are as simple as 
methylations, whereas others involve multiple step additions of aromatic acid derivates and 
sugars (Agris 2004). The best understood modifications are those occurring in the anticodon stem 
and loop domain (ASL). For example, in the wobble position of tRNAs there are the following 
nucleosides - U, C, G or I (inosine), the later is derived from adenosine. Inosine appears to 
substitute A in the position 34 because I binds C and has a wobble capacity to A and U base 
pairing. Besides that, A in the wobble position of the P-site tRNA could destabilize the A-site 
anticodon-codon duplex (Agris 2004). The function of these modifications is not necessarily 
preventing the misreading of near-cognate codons but significantly increase the recognition of 
cognate codons. For example, in yeast genetic deletion of enzymes responsible for modifying 
tRNA wobble position of tRNALys is lethal (Gustilo, Vendeix et al. 2008). Modifications in the 
anticodon domain of tRNA, at purine-37 position, are also related with the maintenance of the 
reading frame. More precisely, natural modifications in the anticodon suppress frameshifting. For 
example, in the absence of the wobble-position modification queuosine, tRNA tyrosine or 
asparagine induce a +1 frameshifting and have a limited effect on -1 frameshifting. So, 
modifications in the anticodon loop at wobble position 34 and 37 appear to restructure the loop 
for correct decoding and are essential for the tRNA folding, secondary and tertiary structure, and 
thus tRNA function (Agris 2004; Gustilo, Vendeix et al. 2008).    
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1.3.2. Aminoacyl tRNAs synthetasis 
 
The aa-tRNAs are formed by the action of the group of enzymes called aaRSs. The role of 
aaRSs in translation is defining the genetic code by accurately pairing cognate tRNAs with their 
corresponding amino acids (Ling, Reynolds et al. 2009). The aaRSs display an overall error rate of 
about 1 in 10,000. The recognition of correct tRNAs by aaRSs is made mostly by specific 
interactions with one or more of the discriminator base (N73), the acceptor stem, and the 
anticodon (Ibba and Soll 2000). However, tRNA identity is not only achieved with isolated 
interactions between single nucleotides and amino acids in aaRSs. The binding of aaRS can induce 
sequence-dependent alternative conformations in tRNA. The discrimination by aaRSs of amino 
acids is more problematic because some amino acids are chemically very similar. To prevent 
potential errors during translation, an intrinsic proofreading activity, called editing, serves to 
eliminate amino acids recognized by a noncognate aaRS (Ibba and Soll 2000). So, the specificity of 
synthetases necessary to keep errors in low level during translation is achieved by preferential 
binding of the cognate amino acid and selective editing of near-cognate amino acids.  
 
Structurally, the aaRSs have separated active and editing sites, as proposed firstly in the 
double-sieve model (two-step substrates selection) (Fersht 1977). According to this, the active site 
Figure 1.7: Structure of the tRNA. On the left a crystallographic structure representing a three-
dimensional structure of the tRNA and, on the right, the cloverleaf secondary structure with the domains 
colored. Amino acid accepting stem (red), dihydrouridine stem and loop domain (DSL) (black), anticodon 
stem and loop domain (ASL) (green), extra loop (EL) (gold), ribothymidine stem and loop (light blue). 
Invariant U33 and amino acid accepting 3´ terminus (C74, C75 and A76) are show (Agris 2004).   
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serves as the first “sieve”, activating cognate, isosteric and smaller amino acids but excluding the 
larger ones. The editing site is the second “sieve”, hydrolyzing misactivated or mischarged amino 
acids but excluding cognate amino acids on the basis of size or hydrophobicity. Regardless of their 
structural and conserved mechanisms of catalysis, aaRSs are divided into two unrelated classes (I 
and II), each with 10 synthetases (Woese, Olsen et al. 2000). This division is based on mutually 
exclusive sequence motifs that reflect distinct active site topologies. Structural studies show that 
in class I aaRSs the active site contains a Rossmann dinucleotide-binding domain and in class II 
aaRSs there is a novel antiparallel β-fold. Another major difference between the two classes is 
related to the binding of tRNA. Class I aaRSs approach the acceptor stem of tRNA from the minor 
groove side with the variable loop facing the solvent, on the other hand class II aaRSs approach 
the major groove side of the acceptor stem and the variable loop faces the synthetase. Structural 
and functional studies have shown that class I isoleucyl-RS, valyl-RS and leucyl-RS share a 
homologous editing domain, whereas class II aaRSs have divergent editing sites that share fewer 
common features (Ling, Reynolds et al. 2009). Another important domain in the aaRSs is the CP1. 
CP1 is a globular insertion domain (INS) positioned approximately 35 Å from the active site and is 
conserved among several class I aaRS. The function of CP1 is to recognize noncognate amino acids 
and edit substrate analogs. Mutations in the CP1 domain region reduce editing activities without 
affecting the aminoacylation efficiency (Ling, Reynolds et al. 2009).  
 
Because the reactions require the capacity of aaRSs to recognize tRNAs as well as small 
chemicals such as amino acids and ATP, the structures of this enzymes are well equipped for 
interacting with diverse molecules (Park, Schimmel et al. 2008). In higher eukaroytes, several 
aaRSs form macromolecular complexes via multivalent protein-protein interactions with three 
aaRS associated proteins at the core. These nonenzymatic cofactors are known as aminoacyl-tRNA 
synthetase-interacting multifunctional protein (AIMP) 1/p43, 2/p38 and 3/p18 (Park, Choi et al. 
2010). The main advantage of these complexes is improving aminoacylation efficiency by 
“channeling” substrates to the ribosome. Besides that, their propensity to form complexes appear 
to be related, in part, to the need of eukaryotic cells for a reservoir of regulatory factors that are 
involved in regulation of transcription, translation  and a number of other signaling pathways. In 
the same way, the tRNA recognition capacity of bacterial threonyl-RS has been adapted for 
regulating translation by interacting with the 5´ and 3´ UTR regions of gene-specific transcripts 
(Park, Schimmel et al. 2008). Another example of the functional versatility of aaRSs is the fact that 
they are utilized in a large number of mechanisms. The roles of aaRSs in such processes can be 
divided in two groups, those that use the aaRSs ability to synthesize an aminoacylated RNA and 
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those that do not depend on aminoacylation. A well characterized example is the role of glutamyl-
RS in porphyrin biosynthesis (where glutamyl-tRNAGlu functions as a precursor for 5-aminolevulinic 
acid) (Ibba and Soll 2000). Another example, is the catalytic activity for glycyl-RS, lysyl-RS, and 
tryptophanyl-RS that have been adapted to synthesize diadenosine polyphosphates (ApnA), which 
are involved in the regulation of glucose metabolism, cell proliferation, and death (Park, Schimmel 
et al. 2008). The expanded functions of aaRSs and their involvement in many mechanisms 
highlight the fact that they can be pathologically associated with various human diseases. A clear 
example is provided for Charcot-Marie-Tooth (CMT) disease. CMT is a neural disease caused by 
heritable dominant mutations in genes that encode for aaRSs causally associated with specific 
pathological condition (Park, Schimmel et al. 2008). Genes for the glycyl-RS and tyrosyl-RS are 
examples of the different genetic loci casually linked to the disease (Antonellis, Ellsworth et al. 
2003; Jordanova, Irobi et al. 2006). Three aaRSs interacting components associated with the 
multisynthetase complex AIMPs have each been linked to signaling pathways relevant to cancers.  
 
 Overall, it is clear that aaRSs present an essential role for cell viability and the inhibition of 
a member of this family will produce deleterious effects on the cell. This assumption lead to the 
early realization that if inhibitors of synthetases could be found that differentiate between 
bacterial and/or fungal enzymes and their human homologs, such compounds might provide a 
means of developing antibacterial and antifungal agents. This fact together with the rapid rise of 
antibiotics-resistant pathogens has put considerable emphasis on the development of novel 
antibiotics, including the search for aaRSs inhibitors (Ibba and Soll 2000).    
1.3.3. Aminoacylation 
 
According to the RNA world hypothesis, in the RNA world the aminoacylation reaction 
was catalyzed by ribozymes (Lee, Bessho et al. 2000). Nevertheless, this happened during a 
relatively short time span as the aaRSs arose early in evolution (Park, Schimmel et al. 2008). The 
aminoacylation process by aaRSs occurs in two steps, namely the activation of amino acids with 
ATP (forming aminoacyl-adenylates – aa-AMPs) and the subsequent transfer of the activeted 
amino acid to tRNA (Figure 1.8) (Ibba and Soll 2000). 
 
In the amino acid recognition and activation of class I aaRSs there is no involvement of 
any covalent or acid-base catalysis, but instead the binding energy provided by enzymes-reactant 
interactions to stabilize the transition state is used. In class II aaRSs the amino acids binding sites 
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are rigid templates that bind the amino acid and ATP substrates in the optimal positions for the 
formation of the transition state by in-line nucleophilic displacement. The selectivity of aaRSs for 
their cognate tRNAs is enhanced by a large contact surface area available during recognition and 
kinetic proofreading during aminoacylation. After its formation, aa-tRNAs are delivered by EF-Tu 
(or EF1α) to the ribosome for peptide synthesis. Elongation factors display selectivity for both the 
amino acids and the tRNA but bind all cognate aa-tRNAs equally well. This contrasts with near-
cognate aa-tRNAs that are bound to elongation factors with different ranges of affinities (Ling, 
Reynolds et al. 2009).   
 
 
 
 
 
 
 
 
 
 
 
 
 
1.3.4. tRNA-dependent amino acid transformations 
 
Besides aminoacylation, another pathway to form aa-tRNA occurs in all organisms. This is 
an indirect pathway which is called tRNA-dependent amino acid transformation (Woese, Olsen et 
al. 2000). The three main tRNA-dependent amino acid transformations are the formylmethionyl-
tRNA synthesis, the selenocysteinyl-tRNA pathway and the pyrrolysine pathway (Sun and 
Caetano-Anolles 2008). The first pathway exists as a requirement of a special methionine tRNA to 
initiate protein synthesis. Bacteria and eukaryotic organelles (mitochondria and chloroplasts) use 
formylmethionine-tRNAfMet to initiate protein synthesis. The tRNAfMet is charged by methionyl-
tRNA with methionine, which is then formylated by methionyl-tRNA formyltransferase (MTF) in 
the presence of the formyl donor N10-formyltetrahydrofolate (FTHF). This reaction involves a 
highly specific protein-tRNA recognition process (Ibba and Soll 2000).  
Figure 1.8: Aminoacylation reaction. Representation of the two steps of the aminoacylation reaction, 
namely, activation of amino acids (aa) by ATP at the aminoacyl-tRNA synthetase (aaRS) active site (AS) 
forming aminoacyl-adenylate (aa-AMP) (1) and subsequent transfer of the amino acid to the 3´ end of the 
tRNA (2). PPi – pyrophosphate. (Ling, Reynolds et al. 2009).  
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The other pathway is related to the formation of a nonstandard amino acid, called 
selenocysteine which is found in proteins of all three domains of life. Selenocysteine is co-
translationally inserted into polypeptides under the direction of the codon UGA (recognized by 
the anticodon UCA) assisted by a distinct elongation factor and a structurally signal in the mRNA 
(Commans and Bock 1999). UGA is a typical stop codon which also codes for Cys and Trp (Sun and 
Caetano-Anolles 2008). For the modification and insertion a special tRNA species is required. This 
tRNA is named tRNASec and the gene encoding it has been characterized in organisms of all three 
kingdoms of life (Xu, Zhou et al. 1999). tRNASec is serylated by seryl-RS (usually with less efficiency 
than the tRNASer) and then the resulting Ser-tRNASec is converted into selenocysteine-tRNASec in a 
two steps pathway (Ibba and Soll 2000). The evolutionary ancestry of Sec is explained for two 
strikingly opposing theories. On one hand, it was proposed that UGA originally codes for Sec, one 
of the earliest amino acids to be charged, and later evolved into the new coding functions. The 
other hypothesis argues that Sec evolved at later stages of the genetic code development (Sun 
and Caetano-Anolles 2008).        
 
Finally, pyrrolysine is co-translationally inserted in response to the UAG codon (amber 
codon) and plays an essential role in the active site of a set of methylamine methyltransferases, 
which allows Methanosarcineace species, Desulfitobacterium hafniense, and glutless worm 
Olavius algarvensis to use methylamines as carbon sources (Heinemann, O'Donoghue et al. 2009; 
Silva, Duarte et al. 2009). The structure of this unusual amino acid is 4-methyl-pyrroline-5-
carboxylate in amide linkage to the ε-amino group of l-lysine (Longstaff, Larue et al. 2007). The 
biosynthetic pathway of this amino acid was the last of the encoded amino acids to be discovered. 
A recent report, from Gaston et al. (2011), shows that pyrrolysine arises from two lysines in a 
pylBCD-dependent pathway. An S-adenosyl-l-methionine (SAM) protein, PylB, mediates a lysine 
mutase reaction whose the product is then linked to a second lysine by PylC previous to oxidation 
by PylD resulting in pyrrolysine (Gaston, Zhang et al. 2011).   
1.3.5. Editing 
 
Linus Pauling and Francis Crick were the first to foresee the need for a quality control 
pathway to distinguish similar amino acids providing a major safeguard against mistranslation 
(Ling, Reynolds et al. 2009). Some amino acids differ only in a methyl group making it difficult for 
aaRSs to distinguish them accurately. AaRSs rely on editing to efficiently discriminate cognate 
from structurally similar non-cognate amino acids. So, the editing activity plays a critical role in 
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vivo, decreasing the frequency of errors by the clearance of mischarged tRNA. Editing activity can 
potentially occur either before (pre-transfer editing) and/or after (post-transfer editing) the 
misactivated amino acid is attached to tRNA (Figure 1.9). Similar to aminoacylation, both tRNA-
dependent pre-transfer and post-transfer editing require aaRSs to specifically recognize their 
cognate tRNAs. In addition to the editing activity that is part of the synthetase there are a few 
instances of freestanding editing domain homologs encoded by various genomes (Chong, Yang et 
al. 2008). Editing is present in approximately half of the aaRSs and the disruption of this activity in 
certain synthetases causes bacterial growth defects and apoptosis in mammalian cells (Ling and 
Soll 2010).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.3.5.1. Pre-transfer editing 
 
Pre-transfer editing was firstly demonstrated in studies with isoleucyl-RS and refers to the 
hydrolysis of misactivated aa-AMP prior to transfer of the aminoacyl moiety to the 3´ end of tRNA. 
Actually, three pathways explain the mechanisms of pre-transfer editing, namely, translocation, 
Figure 1.9: Pre- and post-tranfer editing pathways. Pathway 1 – post-transfer editing. The misactiveted 
amino acid (aa) is first linked to the tRNA and is subsequently translocated from the active site (AS) to 
the editing site (ES) where it is hydrolyzed. Pathways 2-4 – pre-transfer editing. 2 (translocation) – 
Misactivated aminoacyl-adenylate (aa-AMP) is directly translocated to the ES to be hydrolyzed. 3 
(selective release) – Noncogante aa-AMP is release into solution and subjected to spontaneous 
hydrolysis. 4 (active site hydrolysis) – Noncognate aa-AMP is hydrolyzed, at the AS, before the release 
(Ling and Soll 2010).  
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selective release and active site hydrolysis (Ling, Reynolds et al. 2009). An individual aaRS may 
employ one or more pathways of pre-transfer editing.  
 
The translocation model is one in which near-cognate aa-AMP is synthesized at the active 
site but is hydrolyzed at the editing site. This model has been extensively studied for isoleucyl-RS. 
Conformational changes in isoleucyl-RS may preferentially stimulate the translocation of valyl-
AMP, but not the cognate isoleucyl-AMP, either because of tighter binding of isoleucyl-AMP to 
the active site or because of its rejection by the editing site. Selective release is characterized by 
cyclization followed by elimination of misactivated amino acids within the active site. More recent 
studies found that pre-transfer editing could also involve misactivated amino acids hydrolyzed in 
the active site in addition to those selectively released into solution. This notion comes from 
several studies as those which involve two class II aaRS, seryl-RS and prolyl-RS. Seryl-RS, from E. 
coli and S. cerevisiae, presents tRNA-independent pre-transfer editing against various near-
cognate amino acids. In the presence of threonine and ATP, seryl-RS catalyzed the AMP formation 
at a rate 17-fold higher than the spontaneous hydrolysis. The seryl-RS not presents a distinct 
editing site, which implies that the aminoacylation active site both preferentially hydrolyzes and 
selectively releases near-cognate aa-AMP. In a similar study with prolyl-RS in E. coli, same results 
were achieved.  
1.3.5.2. Post-transfer editing 
 
The post-transfer editing was first demonstrated in isoleucyl-RS and phenylalanyl-RS by 
Eldred and Schimmel, and by Yarus (Eldred and Schimmel 1972; Yarus 1972). They found that 
isoleucyl-RS and phenylalanyl-RS catalyzed the hydrolysis of misacylated Val-tRNAIle and Ile-
tRNAPhe, respectively. The mechanism of post-transfer editing requires that the 3´ end of 
mischarged aa-tRNAs travels from the active site to the editing site, which is 30-40 Å away (Ling, 
Reynolds et al. 2009). Structural and modeling studies suggest that acylated 3´-CCA end could be 
directly translocated between the two sites, while the rest of the tRNA molecule remained 
attached to the aaRS.  Class I aaRSs may retain misacylated tRNA long enough for translocation to 
occur, whereas class II are more likely to release it into solution and edit in trans. According to the 
double-sieve model, 3´ end of both cognate and near-cognate aa-tRNAs traffic to the editing site 
however, only near-cognate species can form productive interactions that result in hydrolysis. The 
principal reason for maintaining this editing site specificity is that it is critical for aaRSs to correct 
mistakes without compromising the synthesis of cognate aa-tRNAs. The fidelity of this process is 
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obtained by the discrimination of substrates on the basis of size or hydrophobicity made by 
editing site of aaRS. To avoid accumulation of the misacylated tRNA, the editing site needs to 
catalyze hydrolysis at a rate slightly higher than that of aminoacylation. For that the labile ester 
bond of aa-tRNAs requires low activation energy for hydrolysis.    
1.3.5.3. Trans-editing 
 
Besides pre-transfer and post-transfer editing the accuracy of aminoacylation is 
accomplished from another mechanism. This pathway is called trans-editing and is based on the 
action of distinct domains (editing domains) corresponding to particular structural modules within 
the characteristic synthetase multidomain structure (Ahel, Korencic et al. 2003). Recent studies 
postulate that editing domains of aaRSs may have existed previously as autonomous proteins that 
were incorporated into the respective aaRSs genes later in evolution. The reason for the 
incorporation is likely due to lower specificity of freestanding modules compared with complete 
aaRSs, which can exploit more intricate tRNA contacts. A widespread (from bacteria to humans) 
example of trans-editing system is the homolog of the editing domain of alanyl-RS, AlaXp. The 
editing activity of this small protein clears tRNAAla mischarged with serine and glycine either 
before translocation to or re-sample from the ribosome (Chong, Yang et al. 2008; Guo, Chong et 
al. 2009). The fact that this genome-encoded protein is one of the most distributed through the all 
three kingdoms of life suggests that overcoming the confusion of Gly or, principal, Ser for Ala is a 
major challenge to the cell.             
1.4. mRNA Mistranslation 
1.4.1. Basal error rate in translation 
 
In the course of protein translation two possible classes of errors can happen. Firstly, 
there are missense errors which are due to the replacement of one amino acid by another 
(Gustilo, Vendeix et al. 2008). Most missense errors have little effect on protein function 
(termination codon read-through is a special case of this type) (Farabaugh and Bjork 1999). The 
second type of error is in processivity. The two consequences of this kind of error is premature 
termination of translation and a translational frameshifting (Gustilo, Vendeix et al. 2008). 
 
Missense errors in translation occur at rates of one per 103-104 codons (Drummond and 
Wilke 2008). If we take as an example a protein with an average length (approximately 400 
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codons), at an error rate of 5 x 104, 18% of the molecules of this protein contain, at least, one 
missense substitution. Missense errors occur during aa-tRNA selection either because of reading 
by mischarged cognate-tRNAs or by a non-cognate tRNA. These types of errors are enhanced by 
amino acid starvation proving that competition between cognate and non-cognate aa-tRNAs 
determines in part the frequency of errors (Holland, Ghosh et al. 2010). Examples of this 
phenomenon comes from studies carried out by Holland and co-workers (2010) who showed that 
during chromate (VI) exposure, the depletion of methionine and cysteine are responsible for 
elevated mRNA mistranslation. However, most amino acids substitutions are not harmful to the 
cell. The reason is that they do not eliminate protein function. In contrast, processivity errors 
result in truncated and usually non-functional proteins (Farabaugh and Bjork 1999). From the two 
types of processivity errors premature termination is by far the most common. The mechanism by 
which it occurs is called ribosome editing and is characterized by a spontaneous dissociation of 
peptydil-tRNA from the ribosome (“drop-off”) (Menninger 1977). The reason for drop-off of the 
ribosome from mRNA is the weak interaction between the peptidyl-tRNA with a non-cognate 
amino acid and the mRNA. In the case of translational frameshifting, it precludes completion of a 
nascent peptide chain causing an alteration in the normal reading frame and enhancing the 
probability of the ribosome to encounter a premature termination codon. Besides the 
spontaneous frameshifting and the frameshifting caused by mutant tRNA, there is another type 
called programmed frameshifting (Farabaugh and Bjork 1999). There are genes that have evolved 
sequences that allow the mRNA to re-program the ribosome to change the frame in which it 
initially was set to read. In situations like that the frequency of frameshifting that occurs at a 
programmed site is, approximately, 100% (Gustilo, Vendeix et al. 2008). The first bacterial gene 
that was found to require +1 frameshifting was the E. coli gene prfB, which encodes release factor 
2 (RF2) (Hansen, Baranov et al. 2003). In this case the frameshifting occurs by slippage of peptidyl 
tRNA during a translational pause caused by poor recognition of the codon in the ribosomal A-
site. 
 
It has long been noted that residues directly involved in protein function tend to not 
tolerate substitutions (Drummond and Wilke 2008). Because of that, it has been postulated that 
slow-evolving proteins have more sites committed to function or are more functionally important. 
Alternatively, the reasons that determine the rate of gene evolution are related to their regional 
variation or mutation rate. In fact, some studies reveal that the functional importance of proteins, 
such as essentiality or the number of protein-protein interactions correlates surprisingly weakly 
with evolutionary rate (Drummond, Bloom et al. 2005).        
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1.4.2. mRNA Mistranslation – Negative aspects and positive features 
 
Intuitively mRNA mistranslation is associated only with a bunch of negative consequences 
to the cells and organisms however, in reality, this is not the case. If codon-decoding ambiguity 
only causes proteome disruption and reduces fitness, natural selection should eliminate it (Silva, 
Paredes et al. 2007). However, mistranslation can bring deleterious consequences but certain 
advantageous too.  
 
Using S. cerevisiae was a model, Santos and colleagues (1999) have demonstrated that 
cells with ambiguous genetic codes were able to outcompete wild-type cells under stress (Santos, 
Cheesman et al. 1999). Furthermore, Silva and co-workers (2007) showed that gene expression 
and physiological remodeling is responsible for stress cross-protection and pre-adaptation of cells 
to severe environmental alterations, allowing them to survive and explore new habitats (Silva, 
Paredes et al. 2007). In this same paper, the response to protein misfolding and the subsequent 
elimination or recovery of aberrant proteins was also characterized and up-regulation of 
proteasome activity, induction of stress proteins, cell-wall remodeling and accumulation of 
trehalose and glycogen are observed.  
An additional study in C. albicans (2007) showed that genetic code ambiguity generates an 
unanticipated proteome expansion which can bring some advantageous phenotypes to the cell 
(Gomes, Miranda et al. 2007). This study concluded that, at least in unicellular organisms, 
negative effects of the codon ambiguity can, under some circumstances, be supplanted by its 
capacity to generate new adaptive traits. These conclusions emphasize the hypothesis advocated 
by recent reports that organisms are highly tolerant and readily adapt to genetic code ambiguity. 
Another theory compatible with these results is the co-evolutionary theory of the genetic code, a 
theory as described in this introduction, which postulates that amino acids were gradually 
incorporated into the genetic code.  
 
Besides these potential advantages related to mRNA mistranslation the negative effects 
are always presents. Indeed, flow cytometry analysis and DNA-microarrays, showed that mRNA 
mistranslation destabilizes the genome and increases ploidy (Gomes, Miranda et al. 2007). In a 
study with Schizosaccharomyces pombe (S. pombe), mRNA mistranslation of threonine ACA 
codons as alanine resulted in a series of deleterious effects, namely, mitotic defects, abnormal 
chromosome segregation, aneuploidy and decreased cell viability (Kimata and Yanagida 2004; 
Silva, Duarte et al. 2009). Various studies with S. cerevisiae were also performed and the major 
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deleterious effects, besides the fitness costs, are increased ploidy (up to 4N), blocked mating and 
sexual reproduction, and altered expression of chaperones, proteasome activity and carbohydrate 
metabolism (Moura, Paredes et al. 2010). In a more recent paper (Silva, Duarte et al. 2009) a 
correlation between mRNA mistranslation/protein misfolding and the up-regulation of the 
longevity gene PCN1 was found. The principal insight that comes from this is that Pnc1p can be 
used as a molecular marker of mistranslation that can be used to monitor mistranslation, for 
example, in tumors, aging cells or neurodegenerative diseases.  
 
Therefore, mistranslation above certain levels disrupts the proteome, decreases cell 
fitness and increases cell death (Moura, Carreto et al. 2009). Nevertheless, codon ambiguity can 
also increase proteome diversity which generates genetic and phenotypic diversity. This diversity 
can be explored by natural selection for development, metabolic and regulatory innovation. All of 
this is only possible because both bacteria and eukaryotes are more resistant to mistranslation 
than previously thought (Moura, Carreto et al. 2009; Moura, Paredes et al. 2010). Associated with 
this high level of mistranslation tolerance are the evolution of proteomic and phenotypic novelty.     
1.5. Protein folding and quality control systems 
1.5.1. General features 
 
The folding of the majority of proteins in eukaryotic cells occurs either in the cytosol or in 
the ER. In both compartments the general principles are the same but idiosyncratic pathways 
exist (Sitia and Braakman 2003). Folding in the ER lumen occurs in conditions which are similar to 
the extracellular space in terms of high calcium concentrations but is more oxidizing than the 
cytosol. A set of specialized chaperones and enzymes are also displayed. Many of the proteins 
that suffer maturation in the ER require several post-translational modifications which turn the 
process slower and inefficient. 
 
In association with the folding and with the task of minimizing harmful effects from 
aberrant proteins, cells possess a set of protein quality control mechanisms (PQC) (Gardner, 
Nelson et al. 2005). The reasons for the existence of these mechanisms are easy to understand 
especially in multicellular organisms where development relies on the fidelity of protein secretion 
(Sitia and Braakman 2003). To maintain the efficiency of quality control mechanisms either in the 
cytosol or ER under diverse physiological conditions, living cells develop regulatory circuits that 
monitor levels of available chaperones. Protein chaperones exist in all major cellular 
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compartments and function either by refolding misfolded proteins (for example, Hsp70 and 
Hsp90), binding to misfolded proteins and preventing aggregation (for example, Hsp40), or 
disrupting protein aggregation (for example, Hsp104) (Gardner, Nelson et al. 2005).  
 
Chaperones are the first line of defense against aberrant proteins. Once a potentially 
damaging protein has been identified, the cell responds in three ways. First, cellular factors try to 
rescue misfolded conformations by refolding them. Secondly, the cell sequesters misfolded 
proteins in an attempt to prevent toxicity interactions (aggregates formation) (McClellan, Tam et 
al. 2005). When the proteins cannot refold they must be eliminated by the ubiquitin-proteasome 
system (UPS) in the cytosol. PQC degradation is primarily brought about by protein-ubiquitination 
complexes that mark proteins for proteasomal degradation. Repair and degradative PQC systems 
may not be mutually exclusive (Gardner, Nelson et al. 2005). Quality control systems maintain 
balance between retaining and degrading potentially harmful products and not preventing export 
of biologically active proteins. The role of this mechanism in living cells is of great importance 
because disease can originate from defective degradation. If the rate of synthesis of a protein 
exceeds the combined rates of folding and degradation, a fraction of it will accumulate 
intracellularly. The true action of these aberrant structures is not clear and is unknown if these 
structures are toxic per se or whether they represent a defense mechanism that segregates 
dangerous proteins into specialized ER subcompartments (Sitia and Braakman 2003). In this 
section I will review the principal insights of quality control in the cytosol, ER and a novel pathway 
in the nucleus. 
1.5.1.1. Protein quality control systems in the cytosol 
 
Misfolded proteins can be degraded by various proteases and in different cell 
compartments. However, the main intracellular pathway for the elimination of misfolded proteins 
in eukaryotic cells is the UPS (McClellan, Tam et al. 2005; Yerbury, Stewart et al. 2005). UPS is a 
highly complex and tightly regulated process that plays major roles in a variety of basic cellular 
processes. For its action proteins are targeted through the conjugation of multiple ubiquitin 
molecules with substrates to generate a polyubiquitin degradation signal. Secondly, the 
destruction of tagged proteins by 26S proteasome complex. The latter is composed by two sub-
complexes: a 20S core particle (CP) that carries out the catalytic activity and a regulatory 19S 
particle (RP) (Ciechanover and Brundin 2003). The reaction of the 26S complex is catalyzed by 
deubiquitinating enzymes (DUBs) and the product is a free and reusable ubiquitin. Polyubiquitin 
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chains can be attached to misfolded proteins in the ER lumen but this predominantly occurs 
through the action of ubiquitin ligases and cofactors in the cytosol (Yerbury, Stewart et al. 2005). 
With few exceptions only polyubiquitined substrates are able to reach its proteolytic core. 
Ubiquitination is carried out by three enzymes: an E1 ubiquitin-activating enzyme, E2 ubiquitin-
conjugating enzymes and E3 ubiquitin ligases. Off these three enzymes E3 seems to play a key role 
in the proteolytic cascade since it serve as the specific substrate recognition factors of the system. 
In some proteins an E4 enzyme is required. This enzyme cooperates with E3 ligases to extend the 
polyubiquitin chain (McClellan, Tam et al. 2005).  
1.5.1.2. Protein quality control systems in the ER 
 
Additionally to its function in the folding of proteins, ER plays vital quality control roles 
(Sitia and Braakman 2003). Rapid disposal of folding-incompetent polypeptides produced in the 
ER lumen is instrumental to maintain ER homeostasis (Hebert and Molinari 2007). Before the 
action of quality control mechanisms per se it is necessary to distinguish between native and non-
native proteins. For such, folding or assembly intermediates expose hydrophobic surfaces which 
will interact with ER resident chaperones, as a consequence they are retained in the ER or 
retrieved from the Golgi complex (Sitia and Braakman 2003). To protect unstructured nascent 
chains synthesized in the ER lumen the multisubunit complex responsible for protein degradation, 
the 26S proteasome, has been positioned in the cytoplasm (Hebert and Molinari 2007). 
 
In the ER, proteins are subjected to two quality control mechanisms that respond to the 
presence of misfolded proteins. The primary mechanism is an ER-dedicated stress response 
pathway termed the unfolded protein response (UPR) pathway, which acts to remodel the ER so 
as to increase its folding capacity (Bukau, Weissman et al. 2006). A secondary mechanism, termed 
ER-associated degradation (ERAD), relies on cell-specific factors and facilitates export of individual 
proteins or classes of proteins (Sitia and Braakman 2003). Specifically, it recognizes terminally 
misfolded proteins and retranslocates them across the ER membrane into the cytosol for 
degradation by the ubiquitin-proteasome degradation machinery. Recent studies argue that ERAD 
encompasses a number of different systems, each responsible for the degradation of a certain 
sub-type of proteins. In yeast, for example, there are at least two different surveillance 
mechanisms. The ERAD-L detects membrane and soluble proteins with luminal lesions and ERAD-
C inspects membrane proteins with misfolded cytoplasmic domains (Vashist and Ng 2004). UPR 
and ERAD are intimately related: UPR induction increases ERAD capacity and loss of ERAD leads to 
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constitutive UPR induction (Bukau, Weissman et al. 2006). Even though some proteins can be 
rerouted to and degraded in the endolysosomal vesicle, the main ER function is to act as a test 
bench where molecules destined for the extracellular space are tested for their potential toxicity 
(Sitia and Braakman 2003). ER quality control seems to monitor primarily local structures within 
protein domains. Although with potential deleterious effects to the cells that ultimately can lead 
to proteins aggregation, a certain degree of freedom from quality control is essential for the 
evolution of proteins.       
1.5.1.3. Protein quality control systems in the nucleus 
 
Contrasting with ER, cytoplasm and mitochondria very little is known about PQC in the 
nucleus. Besides the identification of chaperones implicated in protein refolding and 
disaggregation in the nucleus, no clear PQC systems have been established (Gardner, Nelson et al. 
2005). However, nuclear proteins can be damaged by the same stresses that occur in the other 
cell compartments so the cell must have some mechanism to deal with aberrant proteins that 
arise within the nucleus. In fact, aberrant protein accumulation in the nucleus likely underlies the 
pathology of Huntington´s disease (HD) and oculopharyngeal muscular dystrophy (OPMD) (Brais 
2003; Jana and Nukina 2003). A recent study by Gardner et al. (2005) provides evidences for the 
existence of a PQC system that resides within the nucleus and degrades aberrant proteins. The 
defining member of this degradation system is Sanp1, an ubiquitin-protein ligase that mediates 
the ubiquitination of aberrant nuclear proteins. According to this model the action of San1p is 
helped by ubiquitin-conjugating enzymes (probably, Ubc1p and Cdc34p) which ultimately lead to 
the degradation of aberrant proteins by the proteasome (Gardner, Nelson et al. 2005).   
1.6. Protein misfolding and disease 
1.6.1. Diseases 
 
Aberrant proteins and their persistence within the cell can often have deleterious effects 
like, loss of regulation, formation of inactive complexes that compete with functional ones, may 
introduce activities if mislocalized or may assemble into aggregates that eliminate protein 
function and/or cause toxicity (Gardner, Nelson et al. 2005). Such proteins can originate from a 
large number of processes like mutations, transcriptional or translational errors, incorrect folding, 
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imbalance subunit synthesis, improper trafficking or damaging caused by environmental 
conditions or metabolic byproducts (Sitia and Braakman 2003; Gardner, Nelson et al. 2005).  
 
One type of inherited human diseases is caused by mutations in the sequence of a specific 
proteins leading to folding defects. Several of these mutations do not affect the activity of protein 
but significantly slows the polypeptide folding. As a consequence a loss of function conditions 
occurs, in which a membrane or secreted protein is retained and subsequently degraded. 
Examples of this type of diseases are cystic fibrosis, Fabry disease, and nephronegic diabetes 
insipidus (Hebert and Molinari 2007). Therapeutic treatment of these diseases is based on the use 
of chemical pharmacological chaperones that promote and/or accelerate productive folding and 
inhibit ER retention. Misfolding in the ER also causes a variety of congenital defects associated 
with ER storage. These mutations can be found in the secretory cargo leading to its degradation or 
creation of a toxic aberrant by-product which will interfere with the homeostasis of ER 
environment (Hebert and Molinari 2007).  
 
Accumulation of intracellular aberrant proteins is associated with a number of 
neurodegenerative diseases such as Alzheimer, Huntington or Parkinson´s (Gardner, Nelson et al. 
2005; Bukau, Weissman et al. 2006). This prevalence is explained because post-mitotic cells such 
neurons tend to accumulate toxic stress species and cannot dilute them during cell division 
(McClellan, Tam et al. 2005). Paget´s disease is also a condition caused by intracellular 
accumulation of aggregates. In this particular case aggregation is caused by missense mutations of 
the p97/Cdc48/VPC gene that affect the capacity of cells to degrade misfolded proteins (Hebert 
and Molinari 2007). Inclusion body myopathies are associated with severe weakness caused by 
muscle cell accumulating cytoplasmatic aggregates. The clearance of aggregates appears to occur 
through the action of ubiquitin modifications that recruit aggregates species via an independent 
mechanism called autophagy. Autophagy is a process characterized by recognition and 
engulfment of targeted proteins into autophagosome vesicles that will fuse with lysosomes, 
where either the vesicles or their content are broken down (Bukau, Weissman et al. 2006). An 
additional factor, that complicates the foundation of a link between these diseases caused by 
aggregates is the factor that they cannot be considered etiopathological entities, but rather 
syndromes with diverse etiologies (Ciechanover and Brundin 2003). 
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1.7. S. cerevisiae as a biological model 
1.7.1. S. cerevisiae as a biological model – General features 
 
Saccharomyces cerevisiae is a yeast species with large industrial applications, like baking 
or brewing, which was first isolated from the skin of grapes (Pretorius 2000). Morphologically, S. 
cerevisiae cells are round, with 5-10 micrometers in diameter, and her reproduce by a process 
known as budding.  
With 6,275 genes organized in 16 chromosomes, S. cerevisiae was the first eukaryotic 
organism with the genome completely sequenced (sequence was released in 1996). It is also one 
of the most intensively studied eukaryotic model organisms in molecular and cell biology 
(Karathia, Vilaprinyo et al. 2011). Like mammalian cells, yeast cells are distinguished from bacteria 
and archaea by the presence of membrane bound organelles, including a nucleus. Because of 
these morphological similarities yeast cells recapitulate fundamental aspects of eukaryotic 
biology, including “a distinctive process of cell division and genetic transmission, transcriptional 
regulation, biogenesis and function of cellular organelles, protein targeting and secretion, 
cytoskeletal dynamics and regulation, and cellular metabolism”(Khurana and Lindquist 2010). 
  
The conservation of homologous genes in yeast fulfilling the same function is a key factor 
that contributes by its use as a model in several human studies like, aging, regulation of gene 
expression, apoptosis or neurodegenerative disorders (Karathia, Vilaprinyo et al. 2011). Because 
of all these studies, among all the eukaryotes, the interaction network of S. cerevisiae is the best 
understood and the most complete (Skrzypek, Myers-Morales et al. 2003). Another fact which is 
of great importance is that, up to 30% of genes implicated in human diseases may have orthologs 
in the yeast proteome (Karathia, Vilaprinyo et al. 2011). Some of these proteins are already 
categorically associated with a vast group of disorders such as cancer, metabolic disorders or 
neurological and malformation syndromes (Skrzypek, Myers-Morales et al. 2003). A characteristic 
study with S. cerevisiae is the expression of human proteins in yeast. An important example, in 
the context of this thesis, is the expression of human α-synuclein protein (implicated in 
neurodegenerative disorders) in S. cerevisiae. As a result of this study, molecular insights into the 
pathways underlying normal biology of this protein, and the pathogenic consequences of its 
misfolding, were revealed (Zabrocki, Pellens et al. 2005).    
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Besides being biochemically and genetically well understood, the relevance of S. cerevisiae 
to human disease is well established by its conserved genome and cellular biology. S. cerevisiae is 
easily manipulated, grows quickly and is one of the few organisms for which many of the –omics 
techniques have been develop and applied on a global scale (Skrzypek, Myers-Morales et al. 2003; 
Khurana and Lindquist 2010). Because of this, S. cerevisiae is a natural choice for genetic studies, 
like this, associated with mistranslation and production of protein aggregates. 
1.7.2. S. cerevisiae as a neurodegenerative model  
 
Neurodegenerative diseases are a serious public health concern due to ageing 
populations in developed nations. During most of the last century the study of the 
neurodegenerative diseases was restricted to relating the clinical phenotype of the diseases to 
their postmortem neurophatology. Although these observations leads to the identification of 
phatological proteinacious aggregates and patterns of different neuronal vulnerability this 
methodology presented many limitations that only more complex studies recurring to the use of 
eukaryotic models can overcome. These new studies permitted, over the past 15 years, the 
identification of disease causing mutations and misfolded proteins that enabled the creation of 
cellular and animal models of neurodegenerative diseases. Among the cellular models yeasts 
captured key aspects of cellular pathology and provided novel gene-environment connections and 
therapeutic targets in an unparalleled scale (Khurana and Lindquist 2010). 
As already mentioned neurodegenerative diseases, namely, Alzheimer (AD) and 
Parkinson´s diseases (PD) are associated with intracellular porteinacious aggregates. A wide range 
of evidences intimately associated protein misfolding, oligomerization and aggregation with 
neurodegeneration. The reason by which theses processes can be studied in yeast is because of 
the high conservation of the cellular PQC (Scheper and Hoozemans 2009). Another important 
dysfunction related with neurodegenerative diseases is the mitochondrial dysfunction and 
oxidative stress (Knott, Perkins et al. 2008). As in mammalian cells, the yeast mitochondrion is the 
organelle responsible for the production of reactive oxygen species (ROS). The capacity of yeasts 
to grow, or not, in fermentative states allows for the analysis of mitochondrial defects that can 
have deleterious impact in mammalian cells. Besides this, yeast also presents conserved 
mechanisms of cell death and survival that are related with neuronal loss. 
However, as a unicellular organism with cell wall, yeast cells present some limitations as a 
model and, specifically, as a model system for neurodegenerative diseases. The principal one is 
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related with the analyses of aspects based on multicellularity and cell-cell interactions. As 
expected the basic elements of the UPR to ER stress are conversed, however, the response is far 
more complex in mammalian cells. Another example of the limitations is the neuronal 
specializations, like axonal transport or neurotransmitter release. These functions cannot be 
recapitulated in yeasts however the fundamental aspects of these proprieties may be conserved 
(Khurana and Lindquist 2010).  
The objectives of this Master Thesis are: 
1) Engineering of eleven mutagenic tRNAs which generated proteome errors and 
unfolded protein stress responses in S. cerevisiae cells. 
 
2) Characterization of the transformants S. cerevisiae cells, evaluating the impact that 
mutagenic tRNA have in terms of growth rate in standard conditions and under 
conditions of stress, use of phenotypic screens to evaluate the impact that these 
mutations on respiratory capacity of the cells and function of mitochondria. 
 
3) Study the impact of proteome mutagenesis on the viability of cells and evaluate 
whether mistranslation can lead to accumulation of protein aggregates (using GFP-
HSP104). 
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Chapter 2 
2. Material and Methods 
2.1. Strains and growth conditions 
2.1.1. Strains and genotypes 
 
Escherichia coli 
 
JM109, genotype: recA1 SupE44 endA1 hsdR17 (rk–, mk+) gyrA96 relA1 thi Δ(Lac-proAB) [F’, 
traD36, proAB, lacIqlacZ ΔM15] 
 
DH5-α, genotype: fhuA2 Δ(argF-lacZ)U169 phoA glnV44 Φ80 Δ(lacZ)M15 gyrA96 recA1 
relA1 endA1 thi-1 hsdR17  
 
Saccharomycies cerevisiae 
YLL026W, genotype: MATα, his3Δ, leu2Δ0; lys2Δ0, ura3Δ0; YLL026w::kanMX4. 
BY4734, genotype: MATa/α, his3Δ1/his3Δ1, leu2Δ0/leu2Δ0, met15Δ0/MET15, 
LYS2/lys2Δ0, ura3Δ0/ura3Δ0. 
2.1.2. Growth and maintenance of E. coli and S. cerevisiae 
 
E. coli strains were grown at 37°C on nutritionally rich medium liquid broth (LB) [1% (w/v) 
peptone from casein, 0.5% (w/v) yeast extract, and 1% (w/v) sodium chloride (Merck)]. After 
transformation E. coli strains were grown in the LB-Ampicilin medium [LB and 100 μg/ml 
ampicillin sodium (Duchefa, Haarlem)]. Strains were stored at -80°C in 1.5 ml LB-Amp 20% (v/v) 
glycerol. 
 
S. cerevisiae strains were grown at 30°C in either: rich medium in the case of BY4743 wild 
type strain (YPD – 2% glucose; 1% yeast extract and 1% bacto-peptone) or minimal medium in the 
case of YLL026W strain and transformed BY4743 (MM – 0.67% yeast nitrogen base without amino 
acids, 2% glucose, 0.2% drop-out mix with all the essential amino acids (annex A)). Variations in 
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drop-out mixes for the selection of specific were used. BY4743 transformed was grown in MM-
LEU. Solid media were always performed by addition of 2% agar. Transformed strains were stored 
at -80°C in 1.5 ml of the corresponding minimal medium with 40% (v/v) glycerol. All media were 
sterilized by heat in an autoclave before use.  
 
Variations in the MM-LEU medium and slight changes in the growth conditions were also 
utilized under different physiological conditions when the phenotypic screening with the BY4743 
strain was carried out (Table 2.1).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.2.1. Oligonucleotides 
 
Oligonucleotides (Table 2.2) were purchased from IDT-Integrated DNA Technologies 
(Belgium) and were resuspended in ultra miliQ (mQ) water to a final concentration of 100 μM.  
 
 
 
Table 2.1: Description of the stresses that was tested in the phenotypic screening assay as well as 
the conditions for growth and changes to the medium associated. The standard growth conditions 
were temperature 30°C and MM-LEU.   
C 
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2.2.2. Plasmids 
2.2.2.1. Original Plasmids 
 
In this work we used two plasmids to obtain the desired constructions: pRS315 and 
pUA261. Following are their description (plasmids maps and sequence of tRNASer are in annex B).  
 
pRS315 Plasmid of 6018 bp containing the AmpR and LEU2 gene, allowing for selection of 
transformants in LB media with ampicilin or in yeast MM-LEU media, respectively. 
Desired DNA fragments were inserted at unique restriction sites, namely SalI 
(3205) and BamHI (3160). 
Table 2.2: The list of oligonucleotides bellow was used for site-directed mutagenesis, sequencing 
of transformants plasmids, PCR screening and Northern blot. 
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pUA261 Plasmid containing a copy of the C. albicans tRNAUGA
Ser
 inserted in plasmid pRS315. 
The tRNA gene fragment was inserted using the restriction sites of the enzymes 
SalI (3205) and BamHI (3160). C. albicans tRNAUGA
Ser (Assembly 21, Ca21chr1 
335138-337219C (candidagenoma.org)) was amplified using the primers UGAF 
and UGAR.       
2.2.2.2. Constructed plasmids 
 
Using pUA261 as a template, we have created eleven new plasmids carrying mutant 
misreading tRNA genes (Table 2.3). Plasmids maps and sequence are in annex B. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2.3: List of the eleven engineering plasmids constructed based on plasmid pUA261. 
Plasmid pUA261 contains a single copy of the C. albicans tRNAUGA
Ser gene. 
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2.2.3. Site Directed Mutagenesis 
 
With the goal of mutating the anticodon of the tRNAUGA
Ser gene inserted in plasmid 
pUA261, polymerase chain reactions (PCR) followed by incubation with a required restriction 
enzyme were prepared. The PCR reaction contained 10x Pfu buffer with MgSO4, 5 µl, 1 µl dNTPs, 
2.5 µl of each primer (diluted 1/10), 1 µl of Pfu and miliQ water to a volume of 50 µl. The 
thermocycler programme routinely used consisted of a starting incubation temperature of 95°C 
for 2:30 minutes followed by 18 cycles at 95°C during 30 seconds, 55°C during 1 minute and 68°C 
during 7 minutes. After this the PCR reactions were terminated at 37°C. Thermal cycling 
denatured the plasmid and annealed the mutagenic primers containing the desired mutation. 
Because the only plasmids of interest were those carrying mutations, the last step of site directed 
mutagenesis was a digestion of parental methylated and hemimethylated DNA with restriction 
enzyme DpnI, 2 µl.     
 
After the digestion plasmids were quantified into a Nanodrop device, stored at -30°C and 
subsequently sent to sequencing (StabVida) with the respective primers containing the desired 
mutation.     
2.2.4. Preparation of E. coli competent cells 
 
For the preparation of E. coli competent cells, the TFB method was used. Buffers TFB I and 
TFB II were made prepared (annex C) and was used. E. coli JM109 and DH5-α cells were used. The 
protocol began by inoculating 200 µl of cells, from a 5 ml overnight culture, in 5 ml of LB media. 
This culture was incubated at 37°C with 180 rpm until an OD550 = 0.3 (approximately 2 h). When 
OD550 = 0.3 was reached, 4 ml of the anterior culture was inoculated in 100 ml LB and left to grow, 
again, at 37°C with 180 rpm until OD550 = 0.3 (almost 3h). After this, the cells were collected in two 
50 ml falcons, placed in ice for 5 minutes and, centrifuged at 2500 rpm for 5 minutes at 4°C. Later, 
the supernatant was decanted and the two pellets were ressuspended, in 20 ml TFB I (cold) each. 
Under the same conditions, cells were centrifuged again, the supernatant was decanted and the 
pellets ressuspended on 5 ml TFB II (cold). Finally, the cells were incubated in ice for 5 minutes, 
distributed 200 µl aliquots of cells per cold Eppendorf tubes, putted the aliquots in liquid nitrogen 
and frozen at -80°C. 
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2.2.5. DNA Minipreps 
 
Single colonies from a freshly streaked plate were picked and inoculated in 5 ml of LB 
medium with ampicilin. This culture was grown overnight at 37°C with agitation at 200 rpm. 
Bacterial cultures were harvested by centrifugation at 8000 rpm in a microcentrifuge for 2 
minutes at room temperature. Supernatants were decanted and the entire remaining medium 
removed.  
 
For the purification of plasmids, a kit (Fermentas – GeneJETTM Plasmid Miniprep Kit) was 
utilized and the manufacture instructions were followed.  After purification the plasmids were 
quantified using a NanoDrop.  
2.2.6. Transformation of E. coli 
 
Transformation of E. coli was carried by the chemical SOC method (SOC solution 
description in annex C). First aliquots of competent cells were withdrawn from the -80°C freezer 
(200 µl competent cells/transformation reaction). 10 ng of plasmidic DNA were added to 
competent cells (DH5-α). The reagents were mixed and then incubated on ice during 30 minutes, 
followed by 90 seconds at 42°C and 2 minutes on ice. 800 µl of SOC were added to the reaction 
mix, incubated during 1 h at 37°C and centrifuged for 1 minute at 2500 rpm. Supernatants were 
removed (leaving approximately 50 µl) and the pellet was homogenized with a pipette. Finally, 50 
µl of transformation reaction was spread on LB-Ampicilin plates. Plates were left on the bench for 
absorption of liquid excess and then were placed in an incubator overnight at 37°C (16-18 h). 
2.2.7. Yeast-specific techniques 
2.2.7.1. Transformation of yeast cells 
 
Transformation of S. cerevisiae was carried out using the lithium acetate (LiAc) method 
(Gietz and Woods, 2002). For this, overnight cultures were diluted in 10 ml of medium to an OD600 
of 0.05.  The cultures were grown at 30°C, 180 rpm shaking, until an OD600 of 0.4 – 0.5. Cells were 
then harvested by centrifugation in 1.5 ml tubes for 1 minute at 4000 rpm. The supernatant of 
each tube was discarded and the transformation reagents were added to the pellet in the 
following order: 240 μl 50% (w/w) PEG 3500, 36 μl 1.0 M LiAc, 50 μl boiled single-stranded carrier 
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DNA (2 mg/ml) previously denatured and 50 μl of an aqueous solution of the plasmid of interest 
(containing 0.5 – 4 μg of plasmid). Tubes were vortexed until a homogeneous suspension was 
obtained and then incubated at 42°C, in a water-bath, during 40 minutes. The cells were then 
harvested by centrifugation at maximum speed for 1 minute, the transformation mixture was 
discarded and the pellet was carefully resuspended in 200 µl of sterile mQ water. Each suspension 
(10-100 µl) was plated in selective media plates and incubated at 30°C, until isolated 
transformants colonies were visible (3-4 days).   
2.2.7.2. Colony PCR 
 
To check for the correct transformation of yeast cells, a colony PCR was performed using 
intact cells from a colony as template. For this, individual colonies of transformed cells were 
picked from a selective plate, using sterile P10 micropipette tips, transferred into 0.2 ml PCR 
reaction tubes and heat-shocked at 95°C during 10 minutes with 5 µl of mQ sterile water. After 
that, the PCR reagents were added: per tube, 1x Taq buffer (0.2 M), dNTPs (0.04 M), R and F 
primers (0.04 M) and Taq polymerase (1 U/µl – 0.01 M) (Fermentas or Bioron) were added. The 
PCR program consisted of 30 cycles, of denaturing at 95°C during 30 seconds, annealing at 60°C 
for 30 seconds and extension at 72°C during 1:30 minutes. Reaction were performed in a 
MyCyclerTM thermal cycler (BIORAD) and ended with a single incubation at 72°C during 5 minutes.    
2.2.7.3. Agarose gel electrophoresis 
 
DNA molecules were fractionated on agarose gels. Multi-Purpose agarose (Boehringer 
Mannheim) was melted (4 minutes at 500 W) using a microwave oven in TAE 1x (annex C) at 
concentrations of 1% (w/v). When the agarose melted,ethidium bromide (EtBr) (Invitrogen) was 
added to a final concentration of 0.002 % (v/v). Gels were casted on BioRad casting systems. DNA 
samples were then mixed with 6x loading buffer (annex C), by adding 1 µl of buffer for 5 µl of PCR 
sample, loaded into the wells (samples and ladder) and eletrophoresed at 80 V (Power Pac 3000, 
Bio-Rad) for 10 minutes followed by 50 minutes at 100-120 V in submerged horizontal 
electrophoresis systems (Mini-Sub Cell GT, Bio-Rad). The eletrophoresed sample gels were 
exposed to ultraviolet (UV) light using a Gel Doc 2000 Gel Documentation System (BioRad) 
coupled to a PC. The images were acquired and analyzed with the Quantity One software (Bio-
Rad). 
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2.3. Study of the impact of mutation 
2.3.1. Determination of transformation efficiency 
 
For the calculation of transformation efficiency in yeast, the number of cells in each 
suspension of the transformation procedure was quantified. For that, the cell culture that was 
grown until an OD600 of 0.4 – 0.5 was quantified using for a Neubaeur chamber/hemocytometer 
and a microscope. Identical number of cells were plated and the number of colonies per μg of 
DNA used per transformation (0.5 – 4 μg of plasmid) was determined after 3 or 4 days of 
incubation. Results were expressed in number of transformants/μg of DNA.  
2.3.2. Growth curve 
   
Cultures of transformed yeast cells were grown in an incubator at 30°C and 180 rpm until 
stationary phase. In Erlenmeyer´s of 100 ml, 20 ml of the respective media were added followed 
by the necessary volume of cells to achieve OD600 of, approximately, 0.02. With a microplate 
reader, OD600 of all the samples was measured (time 0).Cultures were grown  at 30°C and 180 rpm 
for 6 or 7 hours and OD600 was determined at intervals of 1 hour until cultures reached stationary 
phase. This procedure was carried out with three different clones of each strain and performed in 
triplicate.  
2.3.3. Light microscopy of yeast cells 
 
Since the S. cerevisiae strain YLL026W is tagged at the carboxy-terminal end of the 
HSP104 gene with green fluorescent protein (GFP) it is possible to observe the presence of 
protein aggregates inducing by misreading tRNAs. Transformants were grown overnight at 30°C 
and 180 rpm. When they reached an OD600 of 0.5, preparations for microscopy observation were 
prepared using a layer of agarose. Using an epifluorescence up-right microscope Imager.Z1 (Zeiss), 
and 38 HE GFP filter, approximately 400 cells were observed for counting the presence of protein 
aggregates. This procedure was repeated three times and in each treatment each misreading 
tRNAs was monitored in three independent transformant replicates. Results were expressed in 
number of cells with aggregates/total number of cells.   
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2.3.4. Yeast cell survival 
 
The plating efficiency of yeast cells allows for determination of survival rates since 
colonies arise from single cells (CFU – colony forming units). To determine survival rates cell 
density in liquid cultures in stationary phase was determined by counting the number of cells 
using a Neubauer chamber/hemocytometer. Cultures were allowed to grow at 30°C and 180 rpm 
in an incubator and samples with 100 and 50 cells were taken every 4 days. Plates with the 
appropriated media were also incubated at 30°C until visible colonies (3 or 4 days) appeared. 
After this time CFUs were determined and compared with the number of cells plated (results was 
expressed in percentage).  
2.3.5. Phenotypic screening 
 
Phenotypic screening was performed with all the eleven BY4743 S. cerevisiae transformed 
strains and the control strain which was transformed with pUA261 plasmid. Screening plates (50 
ml of medium) containing the compounds that are described in the section 2.1.2. were prepared. 
For each condition tested prepared 9 plates were prepared.  
 
Transformants were grown overnight and when the exponential phase was reached 
(OD600 between 0.5 and 0.8) cell density was determined by counting the number of cells using a 
Neubauer chamber/hemocytometer. In a 96 wells microtiter plate (called “mother plate”) 200 µl 
of each sample with 1x107 cells and three subsequent dilutions of 1/10 were dispensed from the 
first wells row to the wells right bellow of the first row. Three “mother plates” each with two 
clones of the same transformation and four dilutions (each clone was tested twice) were 
prepared. A robot used those “mother plate” to print cells in three screening plates previously 
prepared. Screening plates were then incubated in different temperature conditions (16°C, 30°C, 
37°C, 42°C) according to the chosen stress during 5 days. Finally, photos of all plates were taken 
and the growth and pattern of colonies was analyzed with the software package ImageJ and 
compared with the respective control (results were expressed in percentage of growth relative to 
the control). 
2.3.6. Total RNA isolation from S. cerevisiae 
 
Total RNA was extracted using a acidic hot-phenol based protocol. Initially, cells were 
grown overnight in controlled conditions until exponentially phase. 25 OD units (volume of the 
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culture x OD600) were collected into 50 ml tubes and harvested briefly (4 minutes, 4000 rpm) in a 
single step centrifugation. Remaining supernatants were poured off and the tubes were 
immediately immersed in liquid Nitrogen (1 minute) and stored at -80°C.    
 
Frozen cells were taken from the -80°C freezer and resuspended in 500 µl of Acidic Phenol 
Cloroform 5:1, pH 4.7 (Sigma), warmed up at 65°C before use. The same volume of TES-buffer (10 
mM Tris pH 7.5, 10 mM EDTA, 0.5% SDS) was added and the tubes were vortexed hard for 20 
seconds with the intent of resuspending the cell pellets. The tubes were incubated during 1 hour 
in a water bath at 65°C, with 20 seconds of vigorously vortexing every 10 minutes. Tubes content 
were transferred to 1.5 ml Eppendorf tube and centrifuged for 5 minutes at 14000 rpm at 4° C. 
600 µl of the water-phase was transferred to a new Eppendorf tube, and 600 µl of Acidic Phenol 
Cloroform 5:1, pH 4.7 was added. Tubes were vortexed for 20 seconds and centrifuged for 10 
minutes at 14000 rpm at 4°C. This last step was repeated with a single alteration – adding 500 µl 
of Acidic Phenol Cloroform 5:1, pH 4.7 instead of 600 µl. Another new Eppendorf tube was taken 
and filled with 400 µl of water-phase from the last step and 400 µl of Chloroform:Isoamyl-alcohol 
25:1 (Sigma), vortexed for 20 seconds and centrifuged for 10 minutes at 14000 rpm at 4°C. Once 
more, the water-phase (350 µl) was transferred to a new Eppendorf tube filled with 35 µl of 
sodium acetate (3 M, pH 5.2) and 800 µl of Ethanol 100% (-20° C). The mix was incubated at -20° C 
for 1 hour. After RNA precipitation, tubes were centrifuged for 5 minutes at room temperature at 
14000 rpm. Carefully, all the liquid was removed without touching the RNA-pellets. The pellet 
were washed with 500 µl of ethanol (80%, -20°C) and centrifuged shortly for 1 minute at room 
temperature, 14000 rpm. All traces of ethanol were removed by air drying of RNA pellet. In the 
last step, RNA-pellet was dissolved in sterile mQ water to a concentration of approximately 10 
µg/µl. Samples were frozen and kept at -80°C freezer.  
2.3.7. Polyacrylamide gel electrophoresis 
 
RNA samples were quantified prior to polyacrylamide gel electrophoresis, using a 
Nanodrop. Polyacrylamide gels were prepared (gel composition in annex C), the electrophoresis 
device was assembled according to the manufactures instructions and approximately 250 µl of 
TEMED (tetramethylethylenediamine) was used to solidify the gel. Electrophoresis was carried out 
for 1 hour at 300 V and the samples were loaded in the wells (25 µg of RNA plus the same volume 
of urea loading buffer). Electrophoresis was carried out at 500 V for more 16 to 20 hours.  
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Gel exposure and RNA transfer for a nitrocellulose membrane was the next step. With this 
purpose the gel was taken from the electrophoresis tank and placed in a plastic sheet during 5 
minutes with 50 ml of TBE1x and 10 µl of ethidium bromide. Following, the gel was exposed under 
UV light and cut leaving only the area containing RNA bands. Ten pieces of whatman paper with 
the same dimension was also cut and, five of them were embedded in TBE 0.25 M and placed in 
the transfer area of an electroblotter, the gel was placed on top of the paper and was covered 
with five other pieces of paper. The transfer was performed for 37 minutes with amperage equal 
to 0.8 times the area of the membrane (in mili ampers).  
2.3.8. Northern blot analysis 
 
Nitrocellulose membranes obtained after the polyacrylamide gel electrophoresis were 
subjected to a Northern blot. Firstly, probes labeling mix (annex C) were prepared and them the 
membranes were placed in a SCHOTT flask, 10 ml of hybridization buffer (annex C) was added, 
and incubated in an oven with agitation, at a temperature 5°C lower than probe melting 
temperature (Tm) for at least 30 minutes. Hybridization buffer was decanted; labelled probe 
prepared previously were added and incubated in an oven with agitation, at Tm -5°C for 12-20 h.  
 
After hybridization membranes were washed. For this, labelled probes were decanted in 
15 ml tubes, stored at 4°C and, 25 ml of pre-warmed washing buffer (annex C) at Tm -5°C was 
added and incubated in the oven at Tm -5°C with agitation for 3 minutes. The washing buffer was 
poured off and last step was repeated. Next, 25 ml of washing buffer at room temperature was 
added and incubated in the oven at Tm -5°C with agitation for 3 minutes. Once more, the washing 
buffer was wasted, the last step was repeated and finally the membranes were closed in a plastic 
bag. 
 
Membranes were exposed to K-screens cleaned by exposing 15 minutes to Screen eraser-
K (Biorad), at room temperature for 1 to 3 days and were scanned using a Biorad Scanner with the 
appropriate settings. 
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Chapter 3 
3. Effects of mistranslation on yeast growth rate and morphology 
3.1. Overview 
 
The genetic code was initially postulated by Crick (Crick, 1968) as a “frozen accident” 
(Crick 1968), because all existing organisms use the same code that as originated from a single, 
closely interbreeding population. The universality of the genetic code is one of the essential 
characteristics of life (Suzuki, Ueda et al. 1997). Crick followed the assumptions of Hinegardner 
and Engelberg (Hinegardner and Engelberg 1963), and postulated that after the primordial 
genetic code expanded to incorporate all twenty amino acids, any alteration in the code would 
result in changes in protein sequences that would be lethal. To explain the origin and evolution of 
the code three main theories were proposed (Koonin and Novozhilov 2009). These three most 
important explanations are the stereochemical theory which postulates that codon assignments 
are dictated by physico-chemical affinity between amino acids and the cognate codons, the co-
evolution theory postulates that the code structure co-evolved with amino acids biosynthesis 
pathway and, the error minimization theory postulates that the principal factor in the code 
evolution was selection to minimize the adverse effects of point mutations and translation errors. 
In a more comprehensive view, the evolution that leads to the standard code can be seen as a 
combination of a frozen accident with selection for error minimization. However, contributions 
from co-evolution (with metabolic pathways) and affinities between amino acids and nucleotides 
triplets cannot be neglected.      
 
It is now known that the standard code is not literally universal as a large number of 
alterations modifications have been discovered. Although any change in the code alters the 
meaning of the code and would introduce translational errors, the idiosyncratic arrangement of 
codon assignments minimizes the impact of errors (Knight, Freeland et al. 2001). Nevertheless, 
the misfolding of proteins always imposes a fitness cost to the cell that may (or not) be related to 
protein function. Protein misfolding compel such costs as a direct toxicity, characterized by 
disruption of membrane integrity or inappropriate interactions, indirect toxicity, increased 
sensitivity to environmental stresses; or, indirect toxicity burdens, due to increased requirement 
of energy to synthesize and detect misfolded proteins (Drummond and Wilke 2008).   
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Any change in the genetic code needs to be explained in light of three assumptions: what 
are the sources of the variability, what limits the alterations (if any) and, what causes a variant 
code to become fixed in a lineage (Knight, Freeland et al. 2001). Genetic code modifications are 
traditionally divided in a number of non-universal codes that have been reported in various non-
plant mitochondrial systems (more frequent), as well as in several nuclear systems (Suzuki, Ueda 
et al. 1997). Sometimes the same alteration occurs in different lineages as illustrated by the 
reassigned of UAA and UAG codons from Stop to Gln in some diplomonads, in several ciliates and 
in the green alga Acetobularia acetabulum. Termination codons are, in fact, particularly unstable 
(Knight, Freeland et al. 2001). For preserving the high degree of fidelity in protein synthesis the 
accuracy in tRNA aminoacylation is crucial (Ruan, Palioura et al. 2008). Therefore, the propriety of 
aaRS to discriminate precisely its cognate amino acid from other structurally related at the 
adenylation reaction step, and its cognate tRNAs from non-cognate ones is critical (Suzuki, Ueda 
et al. 1997). Another important feature is the base-pairs of the charged tRNA with the correct 
codon on the mRNA, at the ribosome. The original codon assignments in an RNA world may 
require direct stereochemical association between the tri-nucleotides and amino acids (Knight, 
Freeland et al. 2001).  
 
The components of the translation apparatus have different capacities for adaptive 
changes. The majority of the non-standard codon engineering assignments have been traced to 
changes in tRNAs. The explanation is that, unlike other components, mutant tRNAs are easy to 
characterize because of their relatively stability and small size. Another important characteristic is 
that single nucleotide substitutions have direct and specific effects on decoding (Giege, Sissler et 
al. 1998). This precise assumption is on the base of this study as we will see in the following 
section. Other components of the translation machinery that create more problems are both 
tRNA-binding and amino-acid binding domains of the aaRS (mutations would probably alter the 
translations of multiple codons) or ribosome (mutations will likely have effect on all codon-
anticodon interactions) (Arnez and Moras 1997). A well studied example of alteration to the 
genetic code is the ambiguous translation of the universal CUG leucine codon as serine in some 
Candida species (Ohama, Suzuki et al. 1993). The most remarkable feature observed in these 
tRNASer CAG is the alteration of the 5´ adjacent nucleotide to the anticodon (position 33) that is 
occupied by G residue (G33) instead of the conserved U residue (U33). This fact is more important 
if we take in consideration that, in all tRNAs reported so far, U33 is necessary for forming the U-
turn structure of the anticodon loop (Suzuki, Ueda et al. 1997). Interestingly, when the Candida 
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tRNA is expressed in S. cerevisiae the result are the production of misfolded peptides that induce 
heat-shock proteins. These proteins allow the transformants to survive under various 
environmental stresses like heat, oxidation, cycloheximide and 1.5 M sodium chloride (Santos, 
Cheesman et al. 1999). This fact shows that, under certain circumstances, ambiguous translation 
is advantageous rather than deleterious. After all, some of the modifications reported so far 
change the basic notion of the genetic code postulated by Crick that the standard was fixed simply 
because all extant life forms share a common ancestor and, remained mainly untouched, because 
of the deleterious effect of codon reassignment (Koonin and Novozhilov 2009).  
 
The experimental strategies chosen to introduce mistranslation and produce protein 
aggregates are based on the utilization of single mutant proteins known to aggregate, or the 
incubation of cells with analogous of proteinogenic amino acids (Suzuki, Ueda et al. 1997). In the 
present thesis, the strategy utilized to induce alterations and mistranslations on yeast cells is 
based on engineered tRNAs. When they actively integrate it in the translation machinery, general 
proteome substitutions occur. With this method, mutations in the proteome were introduced 
without exposing the cells to unnatural compounds that can trigger a number of collateral effects.  
3.2. Results 
3.2.1. Genetic system for the expression of tRNASer of C. albicans in S. cerevisiae 
 
In this thesis mistranslation in S. cerevisiae yeast cells was induced by mutating the 
tRNAUGA
Ser from C. albicans gene, which was previously cloned in pRS315 vector (Mateus 2011), 
and was transformed into the yeast BY4743 and YLL026W strains. Eleven misreading tRNAs that 
introduce different mutations in the yeast proteome were engineered. 
 
The seryl-tRNA synthetase (SerRS) does not interact with the anticodon of serine tRNAs 
and mutations in their anticodon create tRNAs that misincorporate serine at any chosen codons 
(Geslain, Cubells et al. 2010) (Figure 3.1). 
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The effectiveness of the site direct mutagenesis was validated by direct Sanger 
sequencing of the eleven engineered plasmids. Plasmids were them transformed into the S. 
cerevisiae strains YLL026W (haploid) and BY4743 (diploid). Colony PCR was carried out to 
guarantee that the plasmids contained the correct tRNA gene (annex D), and transformation 
efficiencies were determined (number of transformants per µg of DNA) (Figure 3.2).  
  
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A B 
A 
Figure 3.1: Representation of the concept used to create quimeric tRNA
Ser
 (A) and figure of the C. 
albicans serine tRNA (B) (Geslain, Cubells et al. 2010). Chimeric tRNAs are engineered by mutation of the 
wild-type serine anticodon (UGA) in tRNA to specific triplets coding for other amino acids. Serylation 
occurs no matter what the anticodon sequence is. In consequence, expression of chimeric tRNA
Ser
 will 
produce mistranslated proteins.  
 
Figure 3.2: Transformation efficiency of S. cerevisiae strains YLL026W (A) and BY4743 (B) showing the 
mean number of transformants per µg of DNA utilized and SEM (8<n<2). For statistically analysis one-
way ANOVAs were performed followed by a Dunnett’s test to determine the significant differences 
between control pUA261 and tRNA expressing cells. 
 
                  YLL026W 
A 
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As can be seen in the figure 3.2A, for the haploid (YLL026W) strain only the plasmid 
Arginine, encoding serine tRNACCU that misincorporates serine at arginine AGG codons showed 
similar transformation efficiency to the control cells. In the other cases the misreading tRNAs 
decreased transformation efficiency. The diploid BY4743 strain (Figure 3.2B) yielded higher 
number of transformants them the haploid strain and the plasmids carrying cysteine and 
phenylalanine misreading codons tRNAs produced higher number of transformants them the 
other plasmids. The plasmids carrying glutamine, methionine and aspartic acid codons misreading 
tRNAs yielded more transformants them whose carrying arginine, histidine, glutamic acid, 
tryptophan, asparagine and proline codons misreading tRNAs.  
3.2.2. Impact of mistranslation on growth rate in yeast cells 
 
The impact of the eleven engineered mutant tRNASer, and the two control plasmids, on 
the growth rate of the YLL026W and BY4743 strains was also determined. Since the 
transformation efficiency results indicated that the strain BY4743 was less affected by the mutant 
tRNA the growth rate was determined in this diploid strain. The results of the growth rate were 
ploted in percentage of all transformants relative to the control pUA261 (Figure 3.3) and growth 
curves are displayed in annex (Annex E).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3: Mean values and SEM of growth rates of S. cerevisiae strain BY4743. The results 
were normalized considering the growth rate of the control pUA261 as 100%. For statistical 
analysis one-way ANOVA was performed followed by a Dunnett’s test to determine the 
significant differences between control pUA261 mean and the remaining treatments. 
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As described in the literature changes in the meaning of the genetic code introduce 
translational errors that tend to imposes fitness cost to the cells (Keeling and Doolittle 1997). 
These deleterious effects may be related to the loss of protein function and/or direct and indirect 
toxicity (Drummond and Wilke 2008). From the wide range of deleterious effects, the energy 
expenditure in the production of misfolded proteins will affect negatively the growth rate. This 
assumption is observed in the growth rate results obtained (Figure 3.3), as the transformants 
carrying mutant tRNA showed lower growth rate them the control transformants. The most toxic 
tRNAs were those the misincorporated serine at glutamic acid, cysteine and tryptophan codons. 
Histidine and phenylalanine codons misreading tRNAs have affected growth rate, but to a lesser 
extent. 
3.2.3. Mistranslations induce advantageous and deleterious phenotypic alterations 
 
The results above demonstrate that mistranslation affect growth rate of yeast cells, what 
is consistent with the literature data which associates mistranslation with a wide range of 
deleterious effects, cell death and even diseases. However, as mentioned in the opening section 
of this chapter, under some conditions ambiguous translation can be advantageous. Examples of 
that come from previous studies that provide evidences that mistranslating cells are tolerant and 
grow under various environmental stresses like heat, H2O2, cycloheximide and salt (Santos, 
Cheesman et al. 1999).  
 
In order to test if mistranslation can be advantageous under other stress conditions a 
phenotypic screening was carried out by growing the engineering S. cerevisiae strain BY4743 
under a large range of environmental conditions. Different temperatures, ROS scavengers 
(ascorbic acid and glutathione), carbon sources (including non-fermentable carbon sources) and a 
wide range of environmental stressors were tested and a heat map was built (Figure 3.4). To 
facilitate the analyzes a figure compiling the significant differences between the cells transformed 
with mutant tRNAs and control cells with plasmid pUA261 was also made (annex F).   
 
The results of the phenotypic screen were, like all the other results, analyzed by 
comparing cells transformed with mutant tRNA with control pUA261 transformants (figure 3.4). 
The data identified conditions where the transformants do not grow at all (namely, temperature 
42°C, EDTA 0.25 mM and 0.5 mM, and menadione 150 µM), and conditions where the majority of 
the cells transformed with mutant tRNA grows faster them control cells (copper sulfate 2.5 mM, 
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SDS 0.01% and 0.015% and, lithium chloride 0.15 M and 0.3 M). This confirmed previous data 
from Santos and colleagues (1999) showing that under certain advantageous circumstances 
mistranslation can be advantageous. To better understand the results obtained an additional plot 
showing the data of all transformants that grow in copper sulfate 2.5 mM was built (figure 3.5).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4: Heat-map of the phenotypic screen data. The size of the colonies obtained for all the 
transformed cells after 5 days of growth under the stipulated conditions was normalized  to the control 
(size of the colony of the cells transformed with plasmid pUA261 was considered 0%). For statistical 
analysis one-way ANOVA was performed followed by a Dunnett´s test to determine the significant 
differences between control pUA261 mean and the remaining treatments (annex F). Differences to the 
control are represented in green when growth is below the control and red when growth is above the 
control. The final scoring was obtained considering the following values: *** = 3; ** = 2; * = 1 (green * are 
negative and red * are positive values). This graphic shows the transformed cells and treatments group by 
clustering analysis.  
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With exception of the cells transformed with the cysteine codon misreading tRNA the 
others cells grow faster them the control cells. Some of the mutant cells present, inclusively, large 
statistical differences relative to the control pUA261 namely, those that misread arginine and 
glutamic acid codons, while others showed more modest increases in growth rate, namely those 
that misread phenylalanine and methionine.  
 
Grouping of treatments showed that temperature extremes (16°C and 42°C) and pH 
results in slower growth rates relative to control. Slower growth was also observed in cells 
exposed to cadmium chloride (50 and 100 µM), caffeine (2 and 10 mM), geneticin (70 and 200 
mg/l) and, paromomycin (1 mM). Others environmental stressors, like menadione 90 µM, sodium 
chloride 0.5M or calcium chloride, showed also significant differences but, depending on the 
transformant, the growth was slower or faster them that of the control. Regarding the ROS 
scavengers, ascorbic acid (80 mM) and glutathione (40 mM), they showed a positive effect.  
 
Growth on different carbon sources to analyze the respiratory capacity of cells and 
elucitade whether mistranslation interfered with the mitochondrial function were also 
performed. Yeast produces energy through glycolysis (absence of mitochondrial respiration) when 
the carbon sources are galactose or glucose (2%) (Fendt and Sauer 2010). With non-fermentable 
substrates such as ethanol (2% and 5%), sorbitol (1.5 M), acetate (2%), lactate and glycerol (2%) 
Figure 3.5: Graphic showing selective advantages induced by mistranslation. The results were 
normalized considering the size of the colonies of the control pUA261 as 0%. For statistical analysis one-
way ANOVA was performed followed by a Dunnett´s test to determine the significant differences 
between Control pUA261 mean and the remaining treatments. Cells transformed with the tRNA 
misincorporating serine at cysteine codon (UGC) did not grow and her value was considered -100% 
relative to the control.  
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yeast utilizes respiration to obtain energy (Karenlampi, Marin et al. 1981; D´amore 1992; Kiely, 
Cusick et al. 2011). The results obtained in the phenotypic screening for all these compounds 
showed that mistranslation had a big impact on growth in non-fermentable media. In galactose 
(2%) only the transformed with the glutamic acid codon misreading tRNA showed a statistically 
significant increased growth rate above that of the control strain. In non-fermentable substrates 
the impact of mistranslation was highly deleterious. The cells most affected were those 
transformed with tRNAs that misincorporated serine at glutamic acid, cysteine, phenylalanine and 
tryptophan codons which suggested that mitochondrial activity was somehow impaired in these 
cells. The treatments with paromomycin 0.5 mM and without source of carbon did not show 
significant differences between of the transformants.  
 
In order to analyze the tRNA mutants individually a scoring system using the results of the 
statistical analysis (annex F) was performed. This scoring system only takes in to account 
significant differences between the distinctive mutagenic tRNA and discriminates the differences 
given points (in a scale of 1 to 3) if the differences is significant (1 point), highly significant (2 
points) or extremely significant (3 points). When the difference corresponds to a faster grow 
relative to the control the values are positive, differences concerned to slow growth of 
transformants relative to the control pUA261 produced negative values. The values of the scoring 
system ranges from -38 to 4 indicating that the deleterious effects caused by mistranslation are 
larger than the advantageous effects. This analysis also identifies three groups of strains, namely 
those that misincorporated serine at asparagine and aspartic acid codons which did not show 
significant differences relative to the control. Transformants that misincorporated histidine, 
glutamine, methionine and proline codons whose overall score ranges from -1 and 3, which 
displayed significant differences in a maximum of three treatments, being, therefore, mildly 
affected by the mistranslation. And five transformants those misincorporation of serine at 
arginine, glutamic acid, cysteine, phenylalanine and tryptophan strongly affected growth rates in 
the phenotypic screen. These transformants had a minimum of five treatments with strong 
negative growth relative to the control and a score value ranging from 4 to -38. From this group, 
cysteine had a score of -38 and tryptophan -16, which were those with the highest sensitivity to 
the alteration of environmental conditions. Cells that misincorporated serine at glutamic acid 
codons also showed strong growth defects but had a mixed behavior with both negative and 
positive effects on growth. These groups were confirmed be the clustering analyses of the 
transformants displayed in figure 3.4. 
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3.3 Discussion 
 
Mistranslation is supposed to have string impact on protein structure, inducing high level 
of proteome alterations, which should be reflected in the fitness of the cell because it will 
consume a lot of metabolic energy. Our results confirmed this hypothesis. Transformation 
efficiency of the S. cerevisiae strains YLL026W and BY4743 showed that the mutagenic tRNAs are 
toxic. The level of toxicity was dependent on the mutagenic tRNA introduced and the ploidy of the 
strain used. Indeed, the toxicity was more damaging in the haploid strain (YLL026W) than in 
diploid (BY4743) which suggests a possible effect of toxicity “dilution” with the increasing ploidy. 
In the BY4743 strain the copy number of tRNA genes is two-fold higher them in the haploid strain 
and this may explain those differences in the toxicity (Langkjaer, Cliften et al. 2003). In fact, the 
mean number of transformants obtained with the haploid strain was 36.71 colonies/µg of DNA 
which is much lower than the 139.8 colonies/µg of DNA verified in the BY4743 strain.  
 
Next, the degree of toxicity introduced by mistranslation was evaluated by its impact on 
growth rate. Mistranslation in E. coli causes a reduction in growth rate (Stoebel, Dean et al. 2008) 
and our data largely confirmed these studies. Indeed, the cells misincorporating serine at 
tryptophan codons had growth rate which was 42.53% of the growth rate of the pUA261 control 
cells. The explanation for this result is that mistranslation results in proteins that have less overall 
activity and the energetic costs of the proofreading requires a considerable investment of the 
cells resources, which will tend to reduce the growth rate. However, in this thesis, as in the study 
of Stoebel, cells could survive to the errors introduced into the proteome. This may be related to 
the plasticity of protein structure which permits multiple substitutions outside the catalytic active-
site residues. This plasticity buffers against the deleterious effects of mutations, allowing for 
chaperones and proteases to take over in situations where mistakes cannot be corrected. Recent 
results indicate that up to 10% of protein mistranslation is not detrimental (Stoebel, Dean et al. 
2008).     
However, an ambiguous genetic code can produce selective advantages under certain 
environmental conditions (Gomes, Miranda et al. 2007; Silva, Paredes et al. 2007; Nevoigt 2008). 
Studies with S. cerevisiae reveal, inclusively, that approximately 2% of the total number of 
mutations can be beneficial (Joseph and Hall 2004). Our results demonstrate that under some 
stress conditions several of our ambiguous strains growth better than the control non-ambiguous 
strains. For example, cells misincorporating serine in glutamic acid codons grow better in lithium 
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chloride 0.15 M and 0.3 M (37.3% and 104.8%, respectively), them the control strains (annex G). 
Also, cells misincorporating serine at arginine and glutamic acid codons grow faster in copper 
sulfate 2.5 mM (120.3% and 220.6%, respectively) than the control cells. These results support the 
assumptions that some mutations that affect fitness under normal environmental conditions are 
beneficial under other environmental conditions. Nevertheless, beneficial mutations in laboratory 
conditions may be deleterious in nature. Indeed, in complete medium some metabolic pathways 
such as those involved in amino acid biosynthesis are repressed, but are used in natural 
conditions and therefore these metabolic differences may alter the outcome of genetic code 
ambiguity (Joseph and Hall 2004). 
 
Another important finding was that mistranslation has a strong deleterious impact on 
respiratory capacity. Cells misincorporating serine at glutamic acid, cysteine, phenylalanine and 
tryptophan, were the most affect. These results are also consistent with others phenotypes since 
those cells displayed the highest loss of fitness under other environmental conditions. The 
impairment of mitochondrial activity likely has serious energetic consequences that affect growth 
rate. Interestingly, the mistranslating strains behaved similarly to strains harboring petite 
mutations (Wallis and Whittaker 1974; Joseph and Hall 2004). Petite mutants are characterized by 
substantial defects on growth rate that can be inclusively lethal on non-fermentable carbon 
sources. Indeed, the substrate can be responsible for these petite mutations. Of all the amino 
acids misincorporations tested that involved serine at cysteine codons showed the highest loss in 
respiratory capacity. These cells had a phenotypic screening overall scoring of -38. 
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Chapter 4 
4. Mistranslation causes protein aggregation and cell degeneration 
4.1. Overview 
 
Protein synthesis evolved to a level of error rate of 1 in 10,000 (Nangle, Motta et al. 
2006). To safeguard translational fidelity and limit errors several quality control mechanisms exist, 
an example being the proofreading performed by the aaRS; discrimination against misacylated aa-
tRNA by EF-Tu or codon-anticodon alignment in the ribosome (Hendrickson, de Crecy-Lagard et al. 
2004). Quality control mechanisms begin during protein synthesis and end with stress responses 
responsible to manage misfolded proteins throughout the cell (Geslain, Cubells et al. 2010). As 
reported in the Introduction the unfolded protein response (UPR) manages the accumulation of 
misfolded proteins in the lumen of the ER. The accumulation of these peptides will cause the 
release of ER-resident chaperone Grp78 (BiP), which induces three adaptive responses (Geslain, 
Cubells et al. 2010). If these responses do not reduce ER stress pro-apoptotic pathways are 
induced and cytochrome c is release from mitochondria by c-ABL kinase or calcium (Gow and 
Sharma 2003). In the cytosol unfolded proteins triggers the heat-shock response. So, the stress 
response is specific for the cellular compartment being affected.   
 
The misincorporation of amino acids can ultimately lead to accumulation of misfolded 
proteins that may be related with protein aggregation and human disorders (Geslain, Cubells et 
al. 2010). The misfolding of proteins and its inherent cost to the cell can be reduced by some 
adaptations, namely: increasing properly translated proteins, decreasing proteins which misfold 
or unfold due to mistranslation, and decreasing properly translated proteins which rapidly lose 
their native structure (Drummond and Wilke 2008). The diseases associated with mutant proteins 
that cannot adopt stable three-dimensional conformations are collectively termed 
“conformational diseases” (Gow and Sharma 2003). Neurodegenerative diseases, such as 
Alzheimer or Parkinson´s diseases, represent a large class of conformational diseases. In fact, 
neuronal tissues are particularly sensitive to protein misfolding and accumulation of abnormal 
protein aggregates in and around affected neurons is a normal feature of neurodegenerative 
diseases. Contributing to this relationship are the elaborate ramified structures and ordinary cell 
length of many neurons, which confer a relatively high surface-area-to-volume ratio, increasing 
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the probability of disruptive protein-membrane interactions. This feature of the neurons is 
aggravated by the limited neuronal turnover, which makes cell loss more probable and more 
permanent under a chronic stress like the one induced by protein misfolding. These assumptions 
are in line with recent studies on mice which showed that protein misfolding has neurotoxic 
effects.  
 
The objective of the study described in this chapter was to verify if mistranslation affects 
cell viability and formation of protein aggregates. The latter was possible due to the availability of 
the YLL026W strain which carried a GFP-Hsp104 reporter protein.  
4.2. Results 
4.2.1. Effect of regulated mistranslation on cell viability 
 
In the previous chapter, we have shown that misincorporation of serine at various 
cognate codons affects yeasts growth rate and impair mitochondrial activity. The effects of 
mistranslation on cells viability were also studied by growing cells for a long period of time and 
plating them periodically in order to assess the percentage of CFU formed (Figure 4.1).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1: Mistranslation affects cell viability. In order to evaluate cell viability effects, CFUs were 
determined by counting the number of colonies that grow on agar plates (  control pUA261;  
control wild type and mutant transformants). 
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After 4 days of incubation, cell viability of mistranslation cells was always lower them that 
of control pUA261 cells, with the exception of serine misincorporation at histidine codons. Similar 
results were obtained after 9 days of incubation (Figure 4.2A, B). 
 
  
 
 
 
 
 
 
 
 
 
 
 
As it can be seen in the figure 4.2 (A and B) there are significant differences between the 
cell viability of control pUA261 and mistranslation cells. In all cases the mutant cells have lower 
viability. Interestingly, the differences between the control and the misreading cells tend to 
soften over time. At day 4 misreading cells that had significant differences relative to the control 
were glutamic acid and glutamine (***), arginine, cysteine, phenylalanine, tryptophan and 
methionine (**). At day 9 significant differences were found for misreading of glutamic acid, 
phenylalanine, glutamine and proline codons. Intriguingly, cells transformed with the pRS315 
vector alone showed similar results to the misreading cells at days 4 and 9, suggesting that this 
plasmid was a negative impact on cell viability, which can be overcome by expression of the wild 
type serine tRNA. The reason for this unexpected phenotype is unknown.  
4.2.2. Protein aggregates induced by mistranslation 
 
 
In order to determine whether mistranslation induces formation of protein aggregates we 
have monitored such aggregates using S. cerevisiae strain YLL026W (haploid) which expresses the 
heat-shock protein 104 (Hsp104) tagged at the carboxyl terminus with GFP. This reporter was 
constructed by inserting the coding sequence of Aequeorea Victoria (S65T) gene in-frame with the 
yeast HSP104 gene (Huh, Falvo et al. 2003). The choice of the molecular chaperone Hsp104 was 
Figure 4.2: Effects of mistranslation on cell viability. The mean values and SEM for the percentage of 
CFU of S. cerevisiae strain BY4743 growing in minimal media at day 4 (A) and day 9 (B) are shown. For 
statistical analysis one-way ANOVA was performed followed by a Dunnett´s test to determine the 
significant differences between control pUA261 and the remaining treatments. 
 
Day 4 Day 9 
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due to its involvement in the disaggregation of insoluble protein aggregates (Bosl, Grimminger et 
al. 2006; Doyle and Wickner 2009). 
 
Yeast cells expressing the HSP104-GFP fusion reporter were transformed with the same 
mutant tRNA plasmids described previously. The recombinant cells were analyzed by 
epifluorescence microscopy in order to detect protein aggregates. This method does not affect 
tRNA expression and can be used to assess the physiological state of the cell. Another advantage 
of this method is that GFP fluorescence does not require external cofactors and this signal can be 
monitored using a fluorescence microscope without disrupting the cell.  This permits the analysis 
of the timing and grade of stress responses induced by the different type of misreading tRNAs. 
Other common methods used to analyze protein localization in S. cerevisiae have depended on a 
transposon-mediated random epitope tagging and plasmid-based overexpression of epitope-
tagged proteins (Huh, Falvo et al. 2003). However, both methods have the probability of leading 
to abnormal subcellular protein localization.  
 
Transformed yeast cells were grown in liquid media to stationary phase and were 
observed using an epifluorescence microscope (Figure 4.3). Protein aggregation was detected in 
all transformants. Significant statistical differences between strains were observed in cells 
misincorporating serine at cysteine, phenylalanine (**), and proline (***) codons. The percentage 
of protein aggregates was also calculated by determines the number of aggregates per cell and 
the size of the aggregates (Figure 4.4).    
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3: Mean values and SEM for the percentage of protein aggregates present in mistranslating S. 
cerevisiae YLL026W cells. Data were normalized considering the total number of cells counted (≈400) 
and the percentage of cells with aggregates. For statistical analysis one-way ANOVA was performed 
followed by a Dunnett´s test to determine the significant differences between control pUA261 mean and 
the remaining treatments. 
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The data (Figure 4.4) showed that different types of misreading produced distinct types of 
aggregates.  For example, cells that misincorporated serine at proline codons produced more 
aggregates them the others and, in some cases, more them one aggregate was observed per cell 
(typically two or three). Various aggregates per cell were also observed in cells that 
misincorporated serine at glutamic acid codons. Interestingly, in dividing cells the proteins 
aggregates are normally present in the mother cells, and not in the daughter cells. This is a 
phenotype previously reported by Liu et al. (2010) and the explanation is that proteins that 
become damaged in the course of cell growth flow back into the mother cell and leave the young 
bud free of them (Liu, Larsson et al. 2010). The “retrograde transport” is carried out by actin 
A B 
C D 
Figure 4.4: Representative images of the various types of protein aggregates detected by 
epifluorescence microscopy. A - Example of a standard protein aggregate observed (arginine). B – Image 
show increased size of cells misincorporating serine at arginine codons. C – Characteristic image of cells 
misincorporating serine at proline codons. D – Image of yeast misincorporating serine at cysteine codons. 
Yeast cells were observed using a fluorescence microscope (60-100x objectives). 
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Figure 4.5: Representative pictures of yeast flocculation seen in cells that misincorporated serine at 
methionine codons. 
 
filaments, which grow from the growing bud to the mother cell. Such filaments are assembled at 
the tip of the bud in a structure that the authors called a “polarisome,” which is made up of core 
proteins plus some proteins involved in actin polymerization (formins). Finally, cells that 
misincorporated serine at cysteine, phenylalanine and proline codons produced large aggregates 
(Figure 4.4D). 
Cells misincorporating serine at methionine codons showed a very strong flocculation 
phenotype (Figure 4.5). An important note is that self-flocculating yeast strains could be 
advantageous in industrial fermentation as part of the process in bioethanol production (Ma, 
Wakisaka et al. 2010). This finding will be most deeply analyzed in the discussion.   
 
 
 
 
 
 
 
 
4.2.3. Northern blot analyses of tRNASer UGA expression  
 
The expression of the mutagenic tRNA was validated using northern blot analysis. The 
northern blot was performed using total RNA extracted from the transformed cells of the strain 
BY4743 and YLL026W expressing the mutant tRNA that misread proline codons. Total RNA from C. 
albicans strain SN148 was used as a positive control. The original images are presented in the 
annex (annex H). 
   
As can be seen in the figure 4.6, the positive control of the assay showed a strong signal 
indicating that the Northern blot technique was working. The internal controls and the negative 
control pUA315 also produced the expected results. Concerning to membrane hybridized with 
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serine probe, the control pUA261 showed higher RNA expression, which is due to the additional 
copy of tRNASer. The mutagenic tRNAs were expressed at a lower level.    
 
 
  
  
 
 
 
 
 
 
 
 
 
4.3. Discussion 
 
The results of cell viability showed that at day 9, the viability of the mistranslating strains 
was lower them that of control cells. After this time-point the viability showed no differences 
between mutagenic tRNA transformants and controls. Interestingly, the viability of the controls 
pUA261 and pUA315 was different. The additional gene copy of tRNASer is somehow important in 
the maintenance of cell viability even in none mutated cells.  
 
Protein aggregation assays showed that mistranslation induces protein aggregation. In 
particular, tRNAs that misincorporated serine at cysteine, phenylalanine and proline were 
significantly different from the control. The protein aggregation suggests that the UPR was 
activated, confirming previous results from other laboratories (Geslain, Cubells et al. 2010). To 
confirm our results, the activation of proteins like BiP (gene KAR2) or other major components of 
the UPR need to be verified by RT-PCR or Western blot. 
Figure 4.6:  Northern blot analysis of the misreading tRNAs. Top left shows a membrane hybridized with 
the serine probe (A), below is the membrane hybridized with the control probe (glycine) (B). + positive 
control (RNA C. albicans SN148); C1 – Control pRS315; C2 – Control pUA261; Pro– RNA from transformant 
Proline of strain YLL026W. 
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Besides the total number of protein aggregates in a cell population, other characteristics 
were studied, namely, the size of the aggregates and the number of aggregates per cell. The data 
shows that each type of mistranslation has slightly different phenotypes in terms of protein 
aggregation. Cells misincorporating serine at arginine and histidine codons were larger them 
other cells, indication of a possible increase in polyploidy, which may explain why these do not 
have significant differences in the percentage of protein aggregates. As already described, ploidy 
is a factor that influences toxicity and cells with increased ploidy are less susceptive to 
mistranslation and, specifically, will present a lower level of protein aggregation. Ploidy should 
therefore be checked by a flow cytometry.  
As mentioned in the results, the most idiosyncratic phenotype observed was the 
flocculation of the strain that misincorporated serine at methionine codons. This self-flocculation 
may be advantageous in industrial fermentation, particularly in bioethanol production. The 
advantages are production of a higher cell concentration under proper conditions in the 
bioreactor and efficient separation of yeast cells in the fermenting mash (Ma, Wakisaka et al. 
2010). Moreover the methionine transformants did produce significant protein aggregation 
formation. This is a very important feature once stress tolerance is crucial for yeast performance 
in any industrial processes (Nevoigt 2008). However, to verify the relevance of this transformant 
in industrial applications more and specific tests are necessary.    
 
The levels of expression of the mutagenic tRNA were confirmed by northern blot. The 
data showed that our engineered tRNAs were expressed at lower level them the control 
tRNAUGA
Ser, suggesting that mistranslation lowers the tRNA expression.  
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Chapter 5 
5.1. General Discussion 
 
Cells most affect by the deleterious effects of mistranslation at the level of growth rate, 
respiratory capacity, and cell viability were those that misincorporates serine at glutamic acid, 
cysteine, phenylalanine and tryptophan codons. The latter had the lowest growth rate (42.53%) 
and second lowest score in the phenotypic screening assay (-16). Serine misincorporation at 
glutamic acid and cysteine also showed significant differences in the phenotypic assay, although 
the former had advantageous growth under some environmental conditions. In the protein 
aggregation assay cysteine, phenylalanine and proline showed the highest percentage of 
aggregates. On the other hand, serine misincorporation at asparagines and aspartic acid codons 
did not result in significant difference relative to the controls in the conditions tested. The 
exception was their lower transformation efficiency. 
To better comprehend the effects of the mutagenic tRNA on the transformant cells, the 
relation between the anticodon mutated and the amino acid that the mutant anticodon specified 
is showed in Table 5.1. The polar requirement, which is a property derived from paper 
chromatographic mobility of amino acid mixtures in pyrinidine-water, and an unidimensional 
characterization of the amino acids that seems to capture the essence of the way in which amino 
acids are related in the context of the genetic code (Woese, Olsen et al. 2000). This property is the 
simplest way to compare the amino acids and explain the different impact of the various 
mutagenic tRNAs. Indeed, the serine polar requirement is 7.5 and the polar requirements of the 
eleven amino acids that were substituted for serine indicate that cysteine, phenylalanine and 
tryptophan were those which serine replaced the amino acids with lowest polar requirements. In 
the cases of glutamic acid and proline the impact of the replacement was most difficult to explain 
based only on the polar requirement. More specifically, glutamic acid has a polar requirement of 
12.5 and aspartic acid has 13. Serine misincorporation at aspartic acid and asparagine codons did 
not have negative effects in the conditions tested. Conversely, serine misincorporation at proline 
and methionine codons were those were the polar requirement was most similar (6.6 for proline 
and 5.6 for methionine). This indicates that the effects of mistranslation cannot be explained by 
the amino acids polar requirement only. If we considers the structure of the amino acids side 
chains, them phenylalanine, tryptophan and proline have distinct structures that may explain the 
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deleterious effects observed by serine misincorporations. Phenylalanine have a distinct phenyl 
group, tryptophan presents a unique indole ring and proline is the only amino acid that does not 
have a core structure because the alpha amino group is incorporated into the ring. In the case of 
the asparagine and aspartic acid codons, serine misincorporation did not cause significant cell 
alterations which may be explained be the relative similarity of the side chains of these amino 
acids with that of serine. 
 
 
 
 
 
 
 
 
 
 
5.2. Conclusions and Future Work 
 
The results achieved in this thesis show that the methodology used to introduce 
proteome-wide mutagenesis is effective. Mutant tRNAs induce formation of misfolded proteins 
that have serious impact on the fitness of yeast S. cerevisiae. Growth rate reduction, impairment 
of the respiratory activity of mitochondria, loss of cell viability and formation of protein 
aggregates which may activate the UPR response were observed. A relevant, and perhaps one of 
the most important findings established, was the relation between the effects that were 
discovered and the dysfunctions related with neurodegenerative diseases. As mentioned before 
(section 1.7.2.), neurodegenerative diseases are strongly associated with intracellular protein 
aggregation, mitochondrial dysfunction and cell death.  This parallelism is an indication that, at 
least in S. cerevisiae, this methodology and the kind of mutations that were induced in this thesis, 
can be useful in the study of neurodegenerative diseases.  
Table 5.1: Polar requirements of the amino acids codified by each mutagenic tRNA anticodon. The 
amino acids represented in this table were substituted for serine. The polar requirement was taken from 
Woese et al., 2000 (Woese, Olsen et al. 2000). Serine polar requirement is 7.5; 
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 From all the mutagenic tRNA the most deleterious ones were the glutamic acid, cysteine, 
phenylalanine, tryptophan and proline. The deleterious effects can be explained, by the divergent 
characteristics of the amino acids relative to serine. Namely, the polar requirement property. 
Mistranslation can be advantageous in certain circumstances. For example, serine 
misincorporation at glutamic acid codons increased growth rate relative to wild type cells in 
presence of some environmental conditions. Interestingly, serine misincorporation at methionine 
codons produced a floculation phenotype and a series of others advantageous features that can 
be useful in some industrial applications.      
The levels of mistranslation tolerated and UPR activation varies even within an organism. 
It will be interesting to test in future studies the response profile of the UPR and the identification 
of new UPR-related factors that may be induced in the response to the misfolded proteins. The 
ultimate goal will be the identification of all the components of cellular stress response and the 
elucidation of the functional and spatial connections between then. 
The importance of this study is related to the involvement of misfolding proteins in 
neurodegenerative diseases in Humans. Studies in mice, which associetes editing-defective alanyl-
RS to ataxia and neurodegeneration provide direct evidences for a role of mistranslation on 
human diseases. Inability to clear mischarged amino acids like serine and glycine in tRNAAla causes 
misfolding of proteins in neurons and lead to disease. The misacylated aa-tRNA, with the 
exception of neurons, does not exhibit dramatic malfunctions in other tissues. This kind of studies 
allows the scientific community to study cystic fibrosis, Alzheimer diseases or cancer, which affect 
Humans. The connections between the aaRS and the mischarge of tRNA with human diseases 
make this a field of great importance. Future work should clarify the relations between the 
mischarging of tRNAs and identify the pathways involved in the responses. In a superior level, 
integration of this knowledge in eukaryotic multi-cellular organisms should be carried out to 
better understand the causes of neurodegenerative diseases. This will help to develop more 
efficient therapies.  
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Annexes 
Annex A 
 
 Drop-Out Mix: 
Adenine   0.25g 
Alanine    1g 
Arginine   1g 
Asparagine   1g 
Aspartate   1g 
Cysteine   1g 
Glycine    1g 
Histidine   1g 
Inositol    1g 
Isoleucine   1g 
Glutamate   1g 
Glutamine    1g 
Lysine                    1g 
Leucine                2g 
Methionine          1g 
Phenylalanine      1g 
Proline                 1g 
Serine    1g 
Treonine         1g 
Tryptophan            1g 
Tyrosine               1g 
Uracil       1g 
Valine                   1g 
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Annex B 
 Maps of the plasmids and sequence of tRNAUGA
Ser gene 
 
Maps of the plasmids pRS315 and pUA261 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
pRS315: Plasmid used by Mateus (2011) as vector for the mutation of tRNAUGA
Ser
. 
pUA261: Plasmid constructed by Mateus (2011) based on pRS315. Plasmids pUA801 to pUA811, 
engineering during this thesis, have the same map. Unique difference is the anticodon that was 
differentially mutated.  
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Sequence of the tRNAUGA
Ser inserted gene into the pRS315 – Highlight for the anticodon 
 
CAGTATGGATTGCTAGTCCTAGAGAAACCGTGGCCATTTTAGACGATTTAATTGATTTCATAGAAGGTTAG
ATAACAATATATATATATTTGCATGAGCTTTGTGAATCAGCTCCAAAATTGATGTAAAAAAAAAGAGGGCG
TTTGGCGGAGCAAAAAAAATAACGACAACTGCAGGACTCGAACCTGCGCGGGCAAAGCCCAAAAGATTTC
AAGTCTTTCTCCTTAACCGCTCGGACAAGTTGCCTAAATCTCGCTGAAATTAGGGATGCACATAAATCAGTC
CTGGAC 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Anticodon of the tRNAUGA
Ser
 present into the eleven engineering plasmids (pUA801-pUA811).  
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Annex C 
 Solutions and procedures 
 
Buffers TFB I and TFB II 
 
TFBI (100ml)  
o 0.3 g CH3CO2K;  
o 1.2 g RbCl2; 
o 0.147 g CaCl2 or 0.195 g CaCl2.2H2O;  
o 1.0g MnCl2; 
The listed reagents were dissolved in d2H2O and 17.7 ml glycerol 87% was added. pH was 
adjusted to 5.8 with 0.2 M acetic acid. Solution was filtered and stored in 2.5 ml aliquots at -20°C.  
 
TFBII (100ml)  
o 0.24g MOPS Na;  
o 1.1g CaCl2 or 1.457g CaCl2.2H2O;  
o 0.12 RbCl2; 
Reagents were dissolved in d2H2O and 17.7 ml glycerol 87% added. pH was adjusted to 6.5 with 
0.5 M acetic acid NaOH. Solution was filtered and stored in 2.5 ml aliquots at -20°C. 
 
SOC (100 ml) 
o 2 g Tryptone;  
o 0.5 g Yeast extract;  
o 0.05 g NaCl;  
o 1 ml KCl (250 mM);  
Adjust the pH to 7.0 with NaOH (0.5 M) and distilled water added up to 80 ml. After autoclave, 20 
ml of sterile filtered (0.22 μm) 1 M glucose were added. 
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TAE 1x  
 
 
TAE50x 
o Dissolve 242 g of Tris in 500 ml of dH2O; 
o Add 100 ml of Na2EDTA (0.5 M and pH 8.0) and 57.1 of crystallized acetic acid. Adjust the 
volume to 1l adding dH2O; 
Add 20 ml of TAE50x to 980 ml of dH2O. Store at room temperature; 
 
Loading Buffer GB 6x 
o 3.45 ml glycerol 87%;  
o 6.5 ml dH2O;  
o 0.025 g Bromophenol Blue; 
 
Probe Labelling mix 
o 1 µl Oligo (1:10); 
o 10 µl dH2O; 
o 3 µl *γ-32P] ATP; 
o 2 µl Buffer kinase 10x; 
o 2 µl Spermidine 0.1 mM; 
o 1.5 µl T4 kinase;  
 
Hybridization and washing buffer 
20xSSPE 
o 175.3 g NaCl; 
o 27.3 g NaH2PO4; 
o 9.4 g EDTA; 
Adjust the volume to 1l adding dH2O and set the pH to 7.4 (with NaOH); 
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50xDehneart 
o 1 g Ficoll 400; 
o 1 g Polyvinylpyrrolidone (PVP); 
o 1 g BSA; 
Adjust the volume to 100 ml adding dH2O; 
 
Hybridization buffer 
o 3.3 µl 20xSSPE; 
o 1 µl 50xDenheart; 
o 4.7 µl dH2O; 
o  1 µl 10% SDS; 
 
 
Washing buffer 
o 50 µl 20xSSPE; 
o 25 µl dH2O; 
o 425 µl 10% SDS; 
 
Polyacrylamide gel 
TBE10X 
o 108 g Tris; 
o 55 g Boric acid; 
o 40 ml EDTA (0.5 M, pH 8.0); 
Gel 
o 42 g urea; 
o 37.5 ml acrylamide (19:1) Biorrad; 
o 10 ml TBE10x; 
o dH2O to 100 ml; 
Add 1ml of APS 10% and 100 µl of TEMED to catalyze the polymerization of acrylamide.  
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Annex D 
 Agarose gel confirming the efficiency of transformation 
 
 
 
 
 
 
 
 
 
  
Agarose gel resulting from the electrophoresis performed with the transformed cells. The 
presence of the plasmid was confirmed; 
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Annex E 
 Growth curves 
First replicated 
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Second replicated 
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Third replicated 
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Annex F 
 Statistically analyses of the  data from the phenotypic screening 
  
Representation of the significant differences obtain after treating the data resulting from the 
phenotypic screening. The size of the colonies obtain for all the transformed cells was 
normalized  with the control (size of the colony of the cells transformed with plasmid pUA261 
was considered 0%). From statistical analysis one-way ANOVA was performed followed by a 
Dunnett´s test to determine the significant differences between control pUA261 mean and the 
remaining treatments. The significant differences are represented in green when represents a 
growth below the control and red representing growth above this. The final scoring was 
obtained considering the following values: *** = 3; ** = 2; * = 1 (green * are negative and red * 
are positive values).  
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Annex G 
 Graphic illustration of the growth rates  of transformed BY4743 cells in lithium chloride  
 
A) 
 
 
 
 
 
 
B)  
Mean values and SEM for the percentage of the size of the colonies, relatively to the mean values of 
the control pUA261, of S. cerevisiae strain BY4743 growing in regular media with the environmental 
stressor lithium chloride 0.15 M (A) and 0.3 M (B). The results were normalized considering the size 
of the colonies of the C pUA261 0%. From statistical analysis one-way ANOVA was performed followed 
by a Dunnett´s test to determine the significant differences between C pUA261 mean and the 
remaining treatments. Transformants that not grows her value is considering -100% than the growth 
of control cells.   
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 Complete list of the graphics that illustrate the growth of transformed BY4743 cells under 
various conditions tested in phenotypic screening 
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Annex H 
 Northen blot membranes – original images 
A) 
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B) 
 
Images of the two membranes resulting from the northern blot performed with RNA from 
the transformants of S. cerevisiae strains BY4743 and YLL026W. Membrane hybridized with 
the serine probe (A) and the membrane hybridized with a control probe (glycine) (B). 
 
